cephalosporin c has been researched along with Bacterial Infections, Gram-Negative in 359 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (0.84) | 18.7374 |
| 1990's | 88 (24.51) | 18.2507 |
| 2000's | 99 (27.58) | 29.6817 |
| 2010's | 107 (29.81) | 24.3611 |
| 2020's | 62 (17.27) | 2.80 |
| Authors | Studies |
|---|---|
| Czech, M; Holubar, M; Ong'uti, S; Robilotti, E | 1 |
| Lewis, RJ; Morpeth, SC; Tong, SYC | 1 |
| López-Medrano, F; Silva, JT | 1 |
| Abidi, S; Fatima, S; Ishaq, S; Jamil, S; Munawwar, R; Sarfaraz, S; Siddiqui, H | 1 |
| Barbier, F; Buetti, N; Tabah, A; Timsit, JF | 1 |
| Chakraborty, DS; Chatterjee, S; Choudhury, S; Lahiry, S | 1 |
| Chatfield, MD; Donaldson, A; Harris, PNA; Harris-Brown, T; Henderson, A; Lye, D; Paterson, DL; Wright, H | 1 |
| Favier, P; Kumar, L; Luna, R; Pérez, D; Pérez, J; Primost, I; Raffo, C; Serio, E; Torres, D | 1 |
| Danziger, LH; Drwiega, EN; Griffith, NC | 1 |
| Cruz-López, F; Garza-González, E; Maldonado-Garza, HJ; Martínez-Meléndez, A; Morfin-Otero, R; Rodriguez-Noriega, E | 1 |
| Cabañero-Navalón, MD; Garcia-Bustos, V; Salavert Lletí, M | 1 |
| Maseda, E; Suárez de la Rica, A | 1 |
| Fariñas, MC | 1 |
| Aiello, TF; Chumbita, M; Garcia-Vidal, C; Lopera-Mármol, C; Monzo-Gallo, P; Puerta-Alcalde, P | 1 |
| Buonomo, AR; Catania, MR; Gentile, I; Grimaldi, F; Pane, F; Paolillo, R; Picardi, M; Pinchera, B; Zappulo, E | 1 |
| Capdevila, X; Charbit, J; Dagod, G; Dumont, Y; Faivre, G; Larcher, R; Le Moing, V; Maury, C; Villiet, M | 1 |
| Kollef, MH; Windham, S | 1 |
| Boyer, P; Cristinar, M; Danion, F; Garijo, C; Hansmann, Y; Hoellinger, B; Jeannot, K; Lefebvre, N; Reisz, F; Ruch, Y; Schramm, F; Simand, C; Studer, A; Ursenbach, A | 1 |
| Christaki, E; Cross, ELA; Del Toro, MD; Eckmann, C; Friedrich, AW; Giannella, M; Guirao, X; Kluytmans, J; Mutters, NT; Presterl, E; Righi, E; Sganga, G; Tacconelli, E; Tsioutis, C; Visentin, A | 1 |
| Laffont-Lozes, P; Larcher, R; Laureillard, D; Loubet, P; Naciri, T; Sotto, A | 1 |
| Stamm, P; Urmann, E; Wisskirchen, J | 1 |
| Danion, F; Hansmann, Y; Hoellinger, B; Ruch, Y; Schramm, F | 1 |
| Carmona, P; Córdoba-Fernández, M; de la Fuente, C; Domínguez, A; García, L; Guzmán-Puche, J; López-Viñau, T; Machuca, I; Martínez-Martínez, L; Merino, N; Robles, JC; Rodríguez, M; Torre-Cisneros, J; Vaquero, JM | 1 |
| Accordini, S; Azzini, AM; Bazaj, A; Be, G; Coledan, I; Lambertenghi, L; Lo Cascio, G; Mazzaferri, F; Miotti, J; Mirandola, M; Naso, L; Salerno, ND; Tacconelli, E | 1 |
| Acevedo, J; Araos, R; D'Agata, EMC; Ferreccio, C; González, M; Huidobro, LA; Jara, A; Khan, A; Maureira, L; Munita, JM; Paredes, C; Park, BJ; Peters, A; Rioseco, ML; Rivas, L; Sánchez, F; Sepulveda, D; Smith, RM; Soto, PR; Spencer-Sandino, M; Styczynski, A; Undurraga, E; Usedo, P; Wettig, LR | 1 |
| Bartolini, A; Bartoloni, A; Bernardo, M; Bianco, V; Botta, A; Faragona, A; Giacometti, A; Giani, T; Graziani, L; Lagi, F; Morroni, G; Parrella, R; Piccica, M; Rossolini, GM; Spinicci, M; Tavio, M | 1 |
| Bassetti, M; Castaldo, N; Fantin, A; Giacobbe, DR; Vena, A | 1 |
| Cosentino, F; Giannella, M; Viale, P | 1 |
| Campos, J; Diaz Högberg, L; Eckmanns, T; Giske, CG; Grundmann, H; Heuer, OE; Jarlier, V; Johnson, AP; Kahlmeter, G; Monen, J; Monnet, DL; Pantosti, A; Rossolini, GM; Simonsen, GS; van de Sande-Bruinsma, N; Vatopoulos, A; Żabicka, D; Žemličková, H | 1 |
| Dash, S; Gupta, K | 1 |
| Cotta, MO; Dulhunty, JM; Eriksson, L; Harris, P; Malacova, E; Milinovich, GJ; Vickers, ML | 1 |
| Aprile, A; Caio, C; Gona, F; Mezzatesta, ML; Stefani, S | 1 |
| Papp-Wallace, KM | 1 |
| Kharat, AS; Khobragade, K; Palwe, S | 1 |
| Ang, JY; Arrieta, A; Bradley, JS; Johnson, MG; Rhee, EG; Rizk, ML; Yu, B; Zhang, Z | 1 |
| Carvalhaes, CG; Castanheira, M; Flamm, RK; Sader, HS | 1 |
| Adam, HJ; Baxter, M; Golden, AR; Karlowsky, JA; Lagacé-Wiens, P; Walkty, A; Zhanel, GG | 1 |
| Chen, Y; Jiang, S; Lu, X; Shen, P; Xiao, Y; Yang, P | 2 |
| Ang, JY; Arrieta, AC; Feng, EH; Johnson, MG; Larson, KB; Rhee, EG; Rizk, ML; Yu, B; Zhang, Z | 1 |
| Cantón, R; Gomes, R; Martins-Oliveira, I; Pérez-Viso, B; Pina-Vaz, C; Quintas, S; Rodrigues, AG; Silva-Dias, A | 1 |
| Adams, ER; Cuevas, LE; Edwards, T; Evans, K; Hobbs, G; Sasaki, S; Sealey, J; Teethaisong, Y; Williams, C | 1 |
| El-Lababidi, RM; Rizk, JG | 1 |
| Biswas, B; Bivens, BN; Brown, DE; Brownstein, MJ; Burch, AK; Daniels, R; Fackler, J; Gainey, AB; Horne, B; Malagon, F | 1 |
| Araj, GF; Berjawi, DM; El Beayni, NK; Musharrafieh, U | 1 |
| Bassetti, M; Battaglini, D; Giacobbe, DR; Pelosi, P; Vena, A | 1 |
| Ariyasu, M; Bassetti, M; Doi, Y; Echols, R; Ferrer, R; Lodise, TP; Matsunaga, Y; Naas, T; Nagata, TD; Niki, Y; Paterson, DL; Portsmouth, S; Torre-Cisneros, J; Toyoizumi, K; Wunderink, RG | 1 |
| Ariyasu, M; Clevenbergh, P; Echols, R; Kaye, KS; Kollef, M; Matsunaga, Y; Menon, A; Nagata, TD; Pogue, JM; Shorr, AF; Timsit, JF; Wunderink, RG; Zeitlinger, M | 1 |
| Abdul-Mutakabbir, JC; Alosaimy, S; Kebriaei, R; Morrisette, T; Rybak, MJ | 1 |
| Felder-Scott, C; Greenberg, DE; Obuekwe, V; Pybus, CA | 1 |
| Alby, K; Alexander, J; Bartelt, LA; Brown, DE; Brownstein, MJ; Burch, AK; Carr, AL; Cheema, F; Daniels, R; Gainey, AB; Jones, MB; Lachiewicz, AM; Linder, KE; Longworth, S; Miller, MB; Shields, RK; Tompkins, KM; van Duin, D; Warner, NC | 1 |
| De Ponti, F; Gatti, M; Raschi, E | 1 |
| Carvalhaes, CG; Flamm, RK; Shortridge, D; Streit, JM | 1 |
| Kufel, WD; Mastro, KA; Parsels, KA; Steele, JM; Thomas, SJ | 1 |
| Garello, P; Livermore, DM; Mushtaq, S; Vickers, A; Woodford, N | 1 |
| Collings, H; Dillon, R; Enstone, A; Palmer, T; Puzniak, L | 1 |
| Bernardi, M; Castagna, A; Castiglion, B; Ciceri, F; Clerici, D; Corti, C; Farina, F; Giglio, F; Greco, R; Liberatore, C; Lorentino, F; Mastaglio, S; Oltolini, C; Pavesi, F; Peccatori, J; Ripa, M; Scarpellini, P; Tassan Din, C | 1 |
| Bragantini, D; Carrara, E; Cattaneo, P; Chiamenti, M; Ellis, S; Franceschi, F; Giske, CG; Lodise, T; Menchinelli, G; Piddock, LJV; Righi, E; Sanguinetti, M; Savoldi, A; Scudeller, L; Tacconelli, E | 1 |
| Chimhini, G; Chimhuya, S; Chisenga, M; De, S; Ferreyra, C; Fitzgerald, F; Kranzer, K; Malou, N; Mujuru, HA; Olaru, ID; Piton, J; Yeung, S | 1 |
| Garcia, JA; Liang, SY; Long, B; Matlock, A; Moussavi, K | 1 |
| Liang, C; Meng, G; Peng, P; Zhang, X; Zhong, L; Zhou, L | 1 |
| Bourru, T; De Beauvoir, C; Gleize, M; Kyungu, V; Parmeland, L; Pecquet, M; Rousseau, N | 1 |
| Fratoni, AJ; Kuti, JL; Nicolau, DP | 1 |
| Belcher, R; Zobell, JT | 1 |
| Abayneh, M; Akeju, O; Ambachew, R; Bekele, D; Carvalho, MJ; Chan, GJ; Gebreyohannes, Z; Goddard, FGB; Metaferia, G; Milton, R; Odumade, OA; Sands, K; Solomon, S; Thomson, K; Van Wickle, K; Walsh, TR | 1 |
| Bilal, M; Büsker, S; El Tabei, L; Fuhr, U; Krauss, C; Taubert, M | 1 |
| Syed, YY | 1 |
| Falagas, ME; Legakis, NJ; Skalidis, T; Vardakas, KZ | 1 |
| Adkin, R; Chaudhry, A; Hill, R; Hopkins, KL; Livermore, DM; Meunier, D; Mushtaq, S; Pike, R; Staves, P; Woodford, N | 1 |
| Ahir, H; Foo, J; Merchant, S; Prabhu, V; Sarpong, E | 1 |
| Flamm, RK; Huband, MD; Jones, RN; Riedel, S; Sader, HS | 1 |
| Sinkó, J | 1 |
| Echols, R; Katsube, T; Kawaguchi, N; Wajima, T | 1 |
| Aitken, SL; Altshuler, J; Ericsson, CD; Guervil, DJ; Ostrosky-Zeichner, L; Wanger, A | 1 |
| Choi, JJ; McCarthy, MW | 1 |
| Forstner, C; Pletz, MW; Wagenlehner, F; Weis, S | 2 |
| Dueñas Gutiérrez, CJ; Martín Asenjo, M; Martín Guerra, JM | 1 |
| Girotto, JE; Nicolau, DP; Rodriguez, BA | 1 |
| Shirley, M | 1 |
| Attwood, M; Bowker, KE; MacGowan, AP; Noel, AR | 1 |
| Ang, JY; Arrieta, AC; Bradley, JS; Caro, L; Johnson, MG; Larson, KB; Rhee, EG; Rizk, ML; Yang, S; Yu, B | 1 |
| Shantier, SW | 1 |
| Hwang, H; Kim, B | 1 |
| Eckmann, C; Lyon, S; Rojas, LJ | 1 |
| Cheng, J; Feng, X; Hu, Y; Huang, W; Huang, X; Jin, Y; Liao, K; Liu, Y; Lu, J; Xu, Y; Yang, Q; Yu, Y; Zhang, S; Zhou, M | 1 |
| Echols, R; Hackel, MA; Karlowsky, JA; Sahm, DF; Tsuji, M; Yamano, Y | 1 |
| Ariyasu, M; Echols, R; Ferreira, JCA; Machida, M; Nagata, TD; Portsmouth, S; Tenke, P; van Veenhuyzen, D | 1 |
| Naber, KG; Wagenlehner, FME | 1 |
| Adam, HJ; Domalaon, R; Golden, AR; Idowu, T; Karlowsky, JA; Lagacé-Wiens, PRS; Lawrence, CK; Lynch Iii, JP; Noreddin, A; Schweizer, F; Walkty, AJ; Wiebe, K; Zelenitsky, S; Zhanel, GG; Zhanel, MA | 1 |
| Duncan, LR; Flamm, RK; Pfaller, MA; Shortridge, D | 1 |
| Hsu, AJ; Tamma, PD | 1 |
| Duncan, LR; Flamm, RK; Hamed, KA; Mendes, RE; Pfaller, MA; Sader, HS; Shortridge, D; Smart, JI | 1 |
| Alavoine, L; Andremont, A; Benhayoun, M; Bourabha, K; Bridier-Nahmias, A; Burdet, C; Clermont, O; d'Humières, C; Denamur, E; Duval, X; Grall, N; Linard, M; Magnan, M; Massias, L; Mentré, F; Tenaillon, O; Tubiana, S | 1 |
| Hsueh, PR; Hsueh, SC; Jean, SS; Lee, WS | 1 |
| Abrar, S; Ain, NU; Hussain, S; Liaqat, H; Rasheed, F; Riaz, S | 1 |
| Baserni, MN; Jugo, MB; Villar, HE | 1 |
| Adam, HJ; Baxter, MR; Hoban, DJ; Karlowsky, JA; Lagacé-Wiens, PR; Walkty, AJ; Zhanel, GG | 1 |
| Bhalodi, AA; Crandon, JL; Nicolau, DP; Williams, G | 1 |
| Chlebicki, MP; Kwa, AL; Lee, AL; Lee, W; Liew, LT; Lim, CL; Nah, SC; Wan, CN | 1 |
| Jacobus, NV; McDermott, LA; Snydman, DR | 1 |
| Chang, CC; Chang, WN; Chen, SF; Chuang, YC; Huang, CR; Lai, WA; Lu, CH; Tsai, NW | 1 |
| Adam, H; Chung, P; Denisuik, A; Gin, AS; Hoban, DJ; Karlowsky, JA; Lagacé-Wiens, PR; Lynch, JP; Rubinstein, E; Schweizer, F; Walkty, A; Zelenitsky, S; Zhanel, GG | 1 |
| Chan, CY; Jacob-Kokura, S; Kaplan, L | 1 |
| Alves, MD; Behle, TF; De Bacco, G; Luz, DI; Mattiello, F; Pasqualotto, AC; Ribeiro, VB; Tessari, JP; Vieira, FJ; Zavascki, AP | 1 |
| Farrell, DJ; Flamm, RK; Jones, RN; Sader, HS | 1 |
| Long, TE; Williams, JT | 1 |
| Eguchi, H; Hotta, F; Kusujima, K; Kuwahara, T; Mitamura, Y; Naito, T | 1 |
| Seifert, H | 1 |
| Eckmann, C; Solomkin, J | 1 |
| Bassetti, M; Righi, E | 1 |
| Sadikot, RT; Swenson, CE | 1 |
| Abdallah, DI; Estaitieh, N; Ibrahim, A; Jisr, T; Moghnieh, R; Mugharbil, A; Sinno, L; Ziade, F | 1 |
| Liu, J; McLaughlin, MM; Qi, C; Rhodes, NJ; Scheetz, MH | 1 |
| Darouiche, RO; Steenbergen, J; Umeh, O; Wagenlehner, FM; Yuan, G | 1 |
| Chan, JF; Yuen, KY | 1 |
| Keller, LA; Petros, K; Sarwari, AR; Slain, D; Turner, RB | 1 |
| Edwards, JK | 1 |
| Hirsch, EB; Liscio, JL; Mahoney, MV | 1 |
| Arnold, CJ; Benjamin, DK; Cho, N; Chu, VH; Clark, RH; Ericson, J; Hornik, CP; Smith, PB; Tian, J; Wilson, S | 1 |
| Berghofen, A; Krämer, BK; Krüger, B; Mircheva, M; Popa, C | 1 |
| Boyles, T | 1 |
| Kielstein, JT; Schmidt, JJ | 1 |
| Darouiche, RO; Umeh, O; Wagenlehner, FM | 1 |
| Kuti, JL; Lee, BJ; Liu, J; Neely, MN; Nicasio, AM; Nicolau, DP; Rhodes, NJ; Scheetz, MH; Van Wart, S | 1 |
| Chuard, C; Descombes, E; Erard, V; Hemett, OM; Martins, F | 1 |
| Bork, JT; D'Angelo, RG; Heil, EL; Johnson, JK | 1 |
| Moy, S; Park, TE; Sharma, R | 1 |
| Bonnaure-Mallet, M; Ehrmann, E; Fosse, T; Jolivet-Gougeon, A | 1 |
| Addison, NO; Awuah-Mensah, G; Labi, AK; Labi, JE; Obeng-Nkrumah, N | 1 |
| Djukanovic, N; Pejovic, A; Protic, D; Todorovic, Z; Toskovic, B; Zdravkovic, M | 1 |
| Abdalhamid, B; Alamoudi, S; Alshami, A; Alyousef, W; Omara, A; Yahya, R | 1 |
| Amsler, KM; Bush, K; Davies, TA; Jacobs, MR; Shang, W | 1 |
| Andes, DR; Craig, WA | 1 |
| Basso, M; Costa, SF; Gobara, S; Gomez, LB; Levin, AS; Oshiro, I; Paez, JG; Spadão, F | 1 |
| Bassetti, M; Repetto, E | 1 |
| Haldorsen, B; Lundblad, EW; Samuelsen, O; Simonsen, GS; Sundsfjord, A | 1 |
| Echevarria, K; Lewis, JS; Towne, TG | 1 |
| Cheong, HS; Chung, DR; Jung, CW; Kang, CI; Ko, KS; Peck, KR; Song, JH; Wi, YM | 1 |
| Chiquet, C; Cornut, PL | 1 |
| Punpanich, W; Tantichattanon, W; Treeratweeraphong, V; Wongwatcharapaiboon, S | 1 |
| Barbour, A; Derendorf, H; Rand, KH; Schmidt, S | 1 |
| Chin, EK; Kiernan, DF; Saidel, MA; Sclafani, LA | 1 |
| Aillet, S; Bourdais, L; Heusse, JL; Schoentgen, C; Watier, E | 1 |
| Deresinski, SC; Schirmer, PL | 1 |
| Acred, P; Ryan, DM; Sowa, MA; Watts, CM | 1 |
| Eames, T; Grabein, B; Kroth, J; Wollenberg, A | 1 |
| Doherty, JA; Khan, J; Kollef, MH; Micek, ST; Pervez, M; Reichley, RM; Welch, EC | 1 |
| Eb, F; Guillon, H; Mammeri, H | 1 |
| Corey, GR; Nannini, EC; Stryjewski, ME | 1 |
| Chong, Y; Ito, Y; Kamimura, T; Yakushiji, H | 1 |
| Carlone, NA; Cocuzza, C; Furneri, PM; Musumeci, R; Nicoletti, G; Pilloni, AP; Prenna, M; Rigoli, R; Tempera, G; Tufano, MA; Tullio, V; Vitali, LA | 1 |
| Aysev, D; Doğu, F; Erol Cipe, F; Ikincioğulları, A; Sucuoğlu, D | 1 |
| Gázquez, G | 1 |
| Jonnala, S; Mohammed, F; Murki, S; Reddy, A | 1 |
| Dryden, MS; Flamm, RK; Kozlov, RS; Läuffer, JM; Lee, E; Morrissey, I; Quintana, A; Rossolini, GM | 1 |
| Cheatham, SC; Fleming, MR; Healy, DP; Humphrey, ML; Kays, MB; Shea, KM; Smith, DW; Sowinski, KM; Wack, MF | 1 |
| Gupta, S; Muralidharan, S; Srinivasa, H | 1 |
| Adam, HJ; Hoban, DJ; Karlowsky, JA; Laverdière, M; Walkty, A; Zhanel, GG | 1 |
| Al-Hasan, MN; Baddour, LM; Eckel-Passow, JE | 1 |
| Bassetti, M; Ginocchio, F; Mikulska, M | 1 |
| Chen, TY; Lee, YT; Liu, KS; Teng, YH; Tsao, SM; Tsui, TL; Wang, YL | 1 |
| Jayahar Bharathi, M; Murugan, N; Ramakrishnan, R; Ramesh, S | 1 |
| Bäcker, M; Chotikanatis, K; Hammerschlag, MR; Rosas-Garcia, G | 1 |
| Amoureux, L; Bador, J; Drabowicz, A; Duez, JM; Llanes, C; Neuwirth, C; Siebor, E | 1 |
| Beloborodov, VB; Gruver, KP; Kuz'menko, TN | 1 |
| Acosta, F; Cottagnoud, M; Cottagnoud, P; Egerman, U; Läuffer, J; Stucki, A | 1 |
| Belomestnykh, N; Bennett, GJ; Ceglowski, B; Rauch, BJ; Saltman, RL; Schukken, YH; Sharkey, HL; Thomas, MJ; Zadoks, RN; Zurakowski, MJ | 1 |
| Afaneh, CI; Barie, PS; Dakin, GF; Ho, VP; Keel, R; Nicolau, DP; Pomp, A; Rich, BS; Turbendian, H | 1 |
| Borra, PS; El Salabi, A; Samuelsen, Ø; Toleman, MA; Walsh, TR | 1 |
| Green, K; Hughes, DW; Lewis, JS; Maxwell, PR; Perez, KK | 1 |
| Castanheira, M; Farrell, DJ; Jones, RN; Mendes, RE; Sader, HS | 1 |
| Trott, D | 1 |
| Di Conza, J; Gutkind, GO; Power, P; Radice, M | 1 |
| Adams, CA; Cioffi, WG; Connolly, MD; Gregg, S; Heffernan, DS; Monaghan, SF; Stephen, A; Thakkar, RK | 1 |
| Coutinho, AS; de Morais, OO; de Oliveira Carneiro da Motta, J; Gomes, CM | 1 |
| Eller, C; Pfeifer, Y | 1 |
| Ghebremedhin, B | 1 |
| Boĭko, VV; Ivanova, IuV | 1 |
| Ambrose, PG; Bhavnani, SM; Craig, WA; Dudley, MN; Ferraro, MJ; Jones, RN | 1 |
| Arnold, HM; Hampton, NB; Hoban, A; Hoffmann, J; Hollands, JM; Juang, PH; Kollef, MH; McCormick, S; Micek, ST; Reichley, RM; Skrupky, LP; Smith, JR | 1 |
| Akashi, K; Chong, Y; Ito, Y; Kamimura, T; Miyamoto, T; Shimoda, S; Shimono, N; Yakushiji, H | 1 |
| Akins, RL; Drusano, GL; McKinnon, PS; Rybak, MJ; Tam, VH | 1 |
| Chen, JY; Chen, YS; Huang, CK; Lee, SS; Lin, HH; Lin, WR; Liu, YC; Tsai, HC; Wann, SR; Yen, MY | 1 |
| Ingviya, N; Jaruratanasirikul, S; Sriwiriyajan, S | 1 |
| Chang, CF; Chang, YF; Chiang, TS; Lin, WH; Yeh, TM | 1 |
| Blumer, JL; Dul, M; O'Riordan, MA; Rosolowski, B; Salvator, A; Toltzis, H; Toltzis, P | 1 |
| Flores, C; Goldani, LZ; Hadlich, E; Maguilnik, I | 1 |
| Blanco, G; de Mier, C; Famiglietti, A; Juárez, J; Pugliese, L; Rodríguez, CH; Vay, C | 1 |
| Chen, D; Cui, N; Du, B; Liu, D; Long, Y; Rui, X; Shi, Y; Wang, H | 1 |
| BONIECE, WS; HOLMES, DH; REDMAN, CE; WICK, WE | 1 |
| Draghi, DC; Jones, ME; Karlowsky, JA; Sahm, DF; Thornsberry, C; Wenzel, RP | 1 |
| Toltzis, P | 1 |
| Akiyama, K; Hiramatsu, N; Igari, J; Koyama, T; Oguri, T | 1 |
| Draghi, DC; Jones, ME; Karlowsky, JA; Nathwani, D; Sahm, DF; Thornsberry, C | 1 |
| Perry, CM; Scott, LJ | 1 |
| Lee, CH; Liu, JW; Tang, YF | 1 |
| Bassaris, HP; Drosou, E; Gogos, CA; Lekkou, A; Marangos, MN; Skoutelis, A; Starakis, I | 1 |
| Tumah, HN | 1 |
| Angelakis, E; Christakis-Hampsas, M; Katonis, P; Koumantakis, E; Makrigiannakis, A; Orfanoudaki, I; Sifakis, S; Tsatsakis, A | 1 |
| Filik, L; Unal, S | 1 |
| Chatterjee, A; Moland, ES; Thomson, KS | 1 |
| Burgess, DS; Frei, CR | 1 |
| Erdem, H; Kiliç, S; Pahsa, A | 1 |
| Dittrich, E; Guttmann, C; Meyer, B; Schmaldienst, S; Thalhammer, F | 1 |
| Fritsche, TR; Jones, RN; Sader, HS | 1 |
| Lin, CY; Wang, HH | 1 |
| Archambaud, M; Chabanon, G; Conil, JM; Cougot, P; Decun, JF; Georges, B; Houin, G; Saivin, S; Seguin, T; Virenque, C | 1 |
| Andes, D; Craig, WA | 1 |
| Chen, WH; Hsueh, PR; Luh, KT | 1 |
| Jeljaszewicz, J; Mészáros, J; Stachlewska, E; Tołłoczko, T; Tyc, Z | 1 |
| Paterson, DL | 1 |
| Lindeman, CJ; Papp, G; Passmore, CA; Sherington, J; Skogerboe, TL; Stegemann, MR; Weigel, DJ | 1 |
| Benjamin, DK; Cotten, CM; Goldberg, RN; McDonald, S; Poole, K; Stoll, B | 1 |
| Fritsche, TR; Jones, RN; Pottumarthy, S; Sader, HS | 1 |
| Bulitta, J; Kirkpatrick, CM; Lipman, J; Roos, JF | 1 |
| Legout, L; Migaud, H; Mouton, Y; Rosele, B; Roussel-Delvalez, M; Savage, C; Senneville, E; Stern, R; Yazdanpanah, Y | 1 |
| Bedenic, B; Bubonja, M; Budimir, A; Topic, M | 1 |
| Alp, E; Aygen, B; Metan, G; Sumerkan, B | 1 |
| Fraser, VJ; Fridkin, SK; Kollef, MH; Merz, LR; Warren, DK | 1 |
| Kirkpatrick, CMJ; Lipman, J; Roos, JF | 1 |
| Araujo, VR; Carvalho-Dias, VM; Cunha, CA; de Souza, CA; de Souza, M; Godoy, C; Lotfi, CJ; Maiolino, A; Nucci, M; Oliveira, AL; Pasquini, R; Ruiz, MA; Seber, A; Silla, L; Simões, BP; Tanaka, PY; Trabasso, P; Urakawa, P; Zanichelli, MA | 1 |
| Fraser, A; Leibovici, L; Paul, M; Sarid, N; Yahav, D | 1 |
| Jones, ME | 1 |
| Noel, GJ | 1 |
| Chang, SC; Chen, SC; Chen, SY; Chen, TH; Chen, WJ; Chen, YC; Chiang, WC; Chien, KL; Lee, CC; Su, CP; Wu, GH; Yen, AM | 1 |
| Afonso, MR; Albertoni, Ade C; Arkader, R; Cabral, EA; da Silva, DC; de Araujo, OR; Diegues, AR; Louzada, ME | 1 |
| Andrews, J; Brenwald, N; Fraise, A; Jain, S | 1 |
| Coratza, G; Docquier, JD; Mantengoli, E; Musmanno, RA; Rossolini, GM | 1 |
| Abraham, OC; Brahmadathan, KN; Jagannati, M; John, G; Kaul, S; Pitchamuthu, K; Sudarsanam, TD | 1 |
| Iribarren, JL; Jiménez, A; Jiménez, JJ; Lorente, L; Martín, MM; Mora, ML; Palmero, S; Santana, M | 1 |
| Bagchi, P; Bush, K; Ianus, J; Noel, GJ; Strauss, RS | 1 |
| Falagas, ME; Vergidis, PI | 1 |
| Brown, M; Chee, L; Grigg, AP; MacGregor, L; Sasadeusz, J | 1 |
| Deresinski, SC | 1 |
| Anderson, SD; Gums, JG | 1 |
| Choi, EC; Choi, KH; Choi, MJ; Kim, BO; Kim, DJ; Park, NJ; Shim, JS; Yu, YH | 1 |
| Kelly, JW; McAllister, CK; Schrank, JH | 1 |
| Chantarojanasiri, T; Preutthipan, A; Suwanjutha, S; Tanpowpong, K | 1 |
| Chow, JW; Salacata, A | 1 |
| Guthertz, LS; Janda, JM; Kokka, RP; Shimada, T | 1 |
| Jones, RN; Marshall, SA | 1 |
| Nicolau, DP; Nightingale, CH; Onyeji, CO; Quintiliani, R | 1 |
| Jang, TN; Liu, CY; Wang, FD; Wang, LS; Yu, KW | 1 |
| Bouza, E; Díaz, MD; Guerrero, C; Moreno, S; Parras, F; Reina, J | 1 |
| Etienne, JP; Hagège, H; Laurent-Puig, P; Singlas, E; Taburet, AM; Taugourdeau, MC | 1 |
| Swartz, MN | 1 |
| Chong, Y; Kwon, OH; Lee, K | 1 |
| Bickel, KD; Buncke, HJ; Feibel, R; Follansbee, S; Jackson, R; Lineaweaver, WC | 1 |
| Barriere, SL | 1 |
| Bello, H; Dominguez, M; Garcia, A; Gonzalez, G; Mella, S; Zemelman, R | 1 |
| Belpaire, F; Lameire, N | 1 |
| Croce, MA; Fabian, TC | 1 |
| Belohradsky, BH; Gabler-Sandberger, E; Handrick, W | 1 |
| McLeish, WM; Miller, D; Pflugfelder, S; Rubsamen, PE | 1 |
| Ashdown, LR; Koehler, JM | 1 |
| Asbell, PA; Bottone, EJ; Friedman, AJ; Wasserman, D | 1 |
| Cheng, KC; Hsieh, JM; Hur, T | 1 |
| Cuenca Estrella, M; Esteban Moreno, J; Nuñez García, A; Ramos Rincón, JM | 1 |
| López, MM; Martín, C; Merino, J; Navarro, V; Roig, PP; Sánchez, B; Zorraquino, A | 1 |
| Golopykho, LI; Gorshevikova, EV; Nichitaĭlo, ME; Saenko, VF; Viktorov, AP | 1 |
| Liam, CK; Parasakthi, N; Riley, PA | 1 |
| Dankert, J; Kamps, WA; Muis, N | 1 |
| Aisa, ML; Echávarri, B; Ferrer, J; Omeñaca, M; Remacha, MA; Villuendas, C | 1 |
| Lee, CP; Lim, AS; Tan, DT | 1 |
| Kim, IC; Kim, MY; Kim, YZ; Kwak, JH; Oh, JI; Paek, KS | 1 |
| Deshpande, AK; Kaundinya, DV; Shah, SS | 1 |
| Bell-Dixon, C; Itokazu, GS; Kahan, FM; Quinn, JP; Weinstein, RA | 1 |
| Awata, S; Inuzuka, K; Kan, K; Kawai, N; Sakagami, H; Washida, H | 1 |
| Budanov, SV; Khess, R | 1 |
| Bourlinou, PK; Karachalios, GN; Nasiopoulou, DD; Reppa, A | 1 |
| Chiodo, F; Coronado, O; Manfredi, R; Mastroianni, A; Nanetti, A | 1 |
| Deguchi, K; Ishihara, R; Ishii, Y; Nakazawa, A; Suzuki, Y | 1 |
| Chan, JC; Lu, PC | 1 |
| Blahová, J; Králiková, K; Krcméry, V; Kubonová, K | 1 |
| Khan, J; Lucey, DR; Park, MK; Stock, F | 1 |
| Hanaki, H; Nagayama, A; Nomura, S | 1 |
| Barnett, ED; Klein, JO | 1 |
| Cheong, YM; Chiu, C; Chow, C; Kumarasinghe, G | 1 |
| Bergfeld, WF; Rindler, JM; Ruddock, TL | 1 |
| Drezner, D; Heymann, WR | 1 |
| Schmid, P; Shpigel, NY | 1 |
| D'Agata, E; DeGirolami, P; Samore, M; Venkataraman, L | 1 |
| Fraser, V; Kollef, MH; Murphy, D; Pasque, C; Sharpless, L; Vlasnik, J | 1 |
| Ho, SW; Hsueh, PR; Luh, KT; Teng, LJ; Yang, PC | 1 |
| Klastersky, J | 1 |
| Wolff, M | 1 |
| Golusiński, W; Kopeć, T; Kruk-Zagajewska, A; Leszczyńska, M; Obrebowska, Z; Szmeja, Z; Szyfter, W; Wierzbicka, M | 1 |
| Behre, G; Hiddemann, W; Link, H; Maschmeyer, G; Meyer, P; Paaz, U; Wilhelm, M | 1 |
| Harf-Monteil, C; Monteil, H | 1 |
| Mini, E; Mosconi, G; Periti, P | 1 |
| Lyons, CJ; Marshman, WE | 1 |
| Dvoretskiĭ, LI; Iakovlev, SV; Shakhova, TV; Suvorova, MP | 1 |
| Feintzeig, ID; Fogel, MA; Gavin, JP; Hunt, WA; Kim, RC; Nussbaum, PB | 1 |
| Chang, TC; Ko, WC; Wu, HM; Wu, JJ; Yan, JJ | 1 |
| Ahmed, A; Ahmed, QT; Hafiz, S; Majeed, H; Syed, S | 1 |
| Jones, RN; Marshall, SA; Varnam, DJ | 1 |
| Arbo, MD; Barefoot, L; Hariharan, R; Nathan, C; Snydman, DR; Weinstein, RA | 1 |
| Banducci, DR; Klugman, K; Mackay, DR; Manders, EK; Prinsloo, J; Saggers, GC | 1 |
| Biedenbach, DJ; Jones, RN; Kugler, KC | 1 |
| Hay, AJ; Lo, TY | 1 |
| Dolmann, A; Fiss, E; Maesen, FP; Shah, PM; Vetter, N; Wesch, R | 1 |
| Ravaoarinoro, M; Therrien, C | 1 |
| Andrieu, P; Archambaud, M; Chabanon, G; Cougot, P; Decun, JF; Georges, B; Houin, G; Mazerolles, M; Saivin, S; Suc, C; Virenque, C | 1 |
| D'Agata, EM; DeGirolami, P; Samore, M; Venkataraman, L | 1 |
| Hatano, S; Kakeya, N; Kasai, M; Kitagawa, M; Nishimura, K; Shirahase, H; Yoshimi, A | 1 |
| Aswapokee, N; Bowonwatanuwong, C; Chayakul, P; Chetchotisakd, P; Dusitnanond, V; Kulpradist, SA; Leelasupasri, S; Rajanuwong, A; Suttinont, C; Suwangool, P | 1 |
| Agraharkar, M; Galen, M; Klevjer-Anderson, P; Rubinstien, E | 1 |
| Edwards, MS; Noyola, DE | 1 |
| Coffin, SE; Ruth, A; Shah, SS | 1 |
| Akhmedova, LI; Beloborodov, VB; Bogomolova, NS; Bol'shakov, LV; Dekhnich, AV; Iakovlev, VP; Karabak, VI; Malikov, VE; Pavlova, MV; Polikarpova, SV; Rudnov, VA; Sidorenko, SV; Strachunskiĭ, LS | 1 |
| Beloborodova, NV; Biriukov, AV; Krutskikh, EN; Kurchavov, VA; Rogatina, EL; Vostrikova, TIu | 1 |
| Rybkin, AK; Shliapnikov, SA | 1 |
| Summanen, PH | 1 |
| Giamarellou, H | 1 |
| Burgos, A; Campillos, P; Gonzalo, N; López-Lozano, JM; Monnet, DL; Saez, M; Yagüe, A | 1 |
| Christodoulou, C; Dellagrammaticas, HD; Kapetanakis, J; Kourakis, G; Megaloyanni, E; Papadimitriou, M | 1 |
| de Man, P; van den Anker, JN; Verbrugh, HA; Verhoeven, BA; Vos, MC | 1 |
| Beach, ML; Biedenbach, DJ; Johnson, DM; Jones, RN; Pfaller, MA | 1 |
| Fabbri, A; Fanci, R; Leoni, F; Longo, G; Martinez, RL; Paci, C; Pecile, P | 1 |
| Chuang, YC; Ko, WC; Lee, HC; Liu, CC; Wu, JJ | 1 |
| Colardyn, F; Hoste, EA; Vandewoude, KH | 1 |
| Feinfeld, DA; Shah, J | 1 |
| García Morillo, S; Giráldez Gallego, A; Miranda Guisado, ML; Palmero Palmero, C | 1 |
| Boucher, BA; Croce, MA; Fabian, TC; Hanes, SD; Herring, V; Pritchard, E; Wood, GC | 1 |
| Essack, SY | 1 |
| Berman, S; DePauw, B; Feld, R; Ho, W; Keating, A | 1 |
| Cazzola, M | 1 |
| Heiss, M; Kern, WV; Steinbach, G | 1 |
| Adinolfi, LE; Andreana, A; Ragone, E; Sarnataro, G; Tripodi, MF; Utili, R | 1 |
| Chuang, YC; Ko, WC; Lee, HC; Su, CY; Ten, SH; Wu, JJ | 1 |
| Iwatsubo, E; Kawakami, Y; Manabe, N; Matsumoto, T; Takahashi, K | 1 |
| Bruckner, DA; Lechner, A | 1 |
| Deng, W; Gao, B; Hu, J | 1 |
| Apisarnthanarak, A; Dunagan, WC; Dunne, WM | 1 |
| Nikaido, H | 1 |
| Cornaglia, G; Fontana, R; Ligozzi, M; Mazzariol, A | 1 |
| Concia, E | 1 |
| Eller, J; Lode, H; Mauch, H; Raffenberg, M | 1 |
| Cornaglia, G; Fontana, R; Mazzariol, A | 1 |
| Li, Y; Wang, K; Zhao, Y | 1 |
| Barberán, J; Carroquino, G; García Del Salto, L; Gomis, M; González, F; Hernández, M; Hernández-Salván, J; Sánchez, B | 1 |
| Dikov, I; Dimitrov, A; Kostov, I; Nikolov, A; P'nevska, M | 1 |
| Morrison, DC; Opal, SM; Palardy, JE; Parejo, N | 1 |
| Elliott, TB; Harding, RA; Henderson, PL; Landauer, MR; Ledney, GD; Tom, SP; Vigneulle, RM | 1 |
| Goa, KL; Ormrod, D; Scott, LJ | 1 |
| Carmeli, Y; Harbarth, S; Harris, AD; Samore, MH | 1 |
| Barton, MD | 1 |
| Ho, SW; Hsueh, PR; Jean, SS; Luh, KT; Teng, LJ | 1 |
| Choh, H; Nakao, A; Okada, K; Takenaka, N; Takeuchi, Y; Yamashita, Y | 1 |
| Badolati, A; Fontán, PA; Gammella, D; Maskin, B; Spinedi, EG | 1 |
| Conte, MP; Mastromarino, P; Pirillo, MF; Seganti, L; Valenti, P; Visca, P | 1 |
| Dolna, I; Ruczkowska, J | 1 |
| Chambers, ST | 1 |
| Dixon, BA; Issvoran, GS | 1 |
| Hibi, H; Horiba, M; Naide, Y; Suzuki, K | 1 |
| Fujimoto, S; Kobamatsu, Y; Makinoda, S; Okuda, T; Sakuragi, N; Tamaki, J; Tanaka, T; Yamada, T | 1 |
84 review(s) available for cephalosporin c and Bacterial Infections, Gram-Negative
| Article | Year |
|---|---|
Cefiderocol: A New Cephalosporin Stratagem Against Multidrug-Resistant Gram-Negative Bacteria.
Topics: Anti-Bacterial Agents; Carbapenems; Cefiderocol; Cephalosporins; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests | 2022 |
Cefiderocol, a new antibiotic against multidrug-resistant Gram-negative bacteria.
Topics: Adult; Anti-Bacterial Agents; Cefiderocol; Cephalosporins; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans | 2021 |
Current opinion in management of septic shock due to Gram-negative bacteria.
Topics: Anti-Bacterial Agents; Cephalosporins; COVID-19; Diagnostic Tests, Routine; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Pandemics; SARS-CoV-2; Shock, Septic | 2021 |
Cefiderocol: A new Antimicrobial for Complicated Urinary Tract Infection (CUTI) Caused by Carbapenem-resistant Enterobacteriaceae (CRE).
Topics: Adult; Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cefiderocol; Cephalosporins; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Male; Siderophores; Urinary Tract Infections | 2022 |
Pharmacokinetic evaluation of cefiderocol for the treatment of multidrug resistant Gram-negative infections.
Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; Cefiderocol; Cephalosporins; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Iron; Microbial Sensitivity Tests | 2022 |
Efficacy and
Topics: Anti-Bacterial Agents; Carbapenems; Cephalosporins; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Tazobactam | 2022 |
Resistance to beta-lactams in Gram-negative bacilli: relevance and potential therapeutic alternatives.
Topics: Animals; Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactams; Carbapenems; Cattle; Cephalosporins; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Microbial Sensitivity Tests; Quinolones; Tetracyclines | 2022 |
The role of cefiderocol in clinical practice.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cefepime; Cefiderocol; Ceftazidime; Cephalosporins; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa | 2022 |
Clinical experience of cefiderocol.
Topics: Anti-Bacterial Agents; Cefiderocol; Cephalosporins; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Pneumonia, Ventilator-Associated; Urinary Tract Infections | 2022 |
New treatments for multidrug-resistant non-fermenting Gram-negative bacilli Infections.
Topics: Anti-Bacterial Agents; Ceftazidime; Cephalosporins; Drug Combinations; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Tazobactam | 2022 |
How to use new antibiotics in the therapy of serious multidrug resistant Gram-negative infections?
Topics: Anti-Bacterial Agents; Cephalosporins; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacterial Infections; Humans; Imipenem | 2022 |
ESCMID/EUCIC clinical practice guidelines on perioperative antibiotic prophylaxis in patients colonized by multidrug-resistant Gram-negative bacteria before surgery.
Topics: Adult; Anti-Bacterial Agents; Antibiotic Prophylaxis; Carbapenems; Cephalosporins; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Male; Monobactams; Prospective Studies | 2023 |
Antibiotic therapy for nonfermenting Gram-negative bacilli infections: future perspectives.
Topics: Anti-Bacterial Agents; Cefepime; Cephalosporins; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests | 2023 |
MDR/XDR/PDR or DTR? Which definition best fits the resistance profile of Pseudomonas aeruginosa?
Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; Cephalosporins; Drug Resistance, Multiple; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Seizures | 2023 |
Modifiable risk factors for multidrug-resistant Gram-negative infection in critically ill burn patients: a systematic review and meta-analysis.
Topics: Aminoglycosides; Anti-Bacterial Agents; Burns; Carbapenems; Cephalosporins; Critical Illness; Cross Infection; Drug Resistance, Multiple; Gram-Negative Bacterial Infections; Humans; Hydrotherapy; Intensive Care Units; Penicillins; Respiration, Artificial; Risk Factors; Urinary Catheters; Vascular Access Devices | 2019 |
The latest advances in β-lactam/β-lactamase inhibitor combinations for the treatment of Gram-negative bacterial infections.
Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; Boronic Acids; Cephalosporins; Clinical Trials as Topic; Drug Combinations; Gram-Negative Bacterial Infections; Heterocyclic Compounds, 1-Ring; Humans; Meropenem; Tazobactam | 2019 |
Preserving the Dwindling β-lactams-Based Empiric Therapy Options for Gram-Negative Infections in Challenging Resistance Scenario: Lessons Learned and Way Forward.
Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactams; Cephalosporins; Drug Combinations; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Penicillins | 2020 |
Cefiderocol: A Siderophore Cephalosporin.
Topics: Adult; Anti-Bacterial Agents; Cefiderocol; Cephalosporins; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Molecular Structure; Siderophores; Urinary Tract Infections | 2020 |
The role of new antimicrobials for Gram-negative infections in daily clinical practice.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Azabicyclo Compounds; beta-Lactams; Carbapenems; Cefiderocol; Ceftazidime; Cephalosporins; Drug Combinations; Drug Resistance, Bacterial; Gram-Negative Bacterial Infections; Humans; Imipenem; Microbial Sensitivity Tests; Polymyxins; Sisomicin; Tazobactam; Tetracyclines | 2020 |
Cefiderocol: A Novel Siderophore Cephalosporin against Multidrug-Resistant Gram-Negative Pathogens.
Topics: Anti-Bacterial Agents; Cephalosporins; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests | 2020 |
Real-world use of ceftolozane/tazobactam: a systematic literature review.
Topics: Cephalosporins; Comorbidity; Critical Illness; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacterial Infections; Humans; Intraabdominal Infections; Pseudomonas Infections; Respiratory Tract Infections; Tazobactam; Urinary Tract Infections | 2021 |
Systematic review and meta-analysis of in vitro efficacy of antibiotic combination therapy against carbapenem-resistant Gram-negative bacilli.
Topics: Amikacin; Anti-Bacterial Agents; Azabicyclo Compounds; Carbapenems; Ceftazidime; Cephalosporins; Colistin; Drug Combinations; Drug Resistance, Bacterial; Drug Synergism; Drug Therapy, Combination; Fosfomycin; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; In Vitro Techniques; Microbial Sensitivity Tests; Polymyxins; Rifampin; Tazobactam; Tobramycin | 2021 |
Advances in novel antibiotics to treat multidrug-resistant gram-negative bacterial infections.
Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Boronic Acids; Cefiderocol; Ceftazidime; Cephalosporins; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Design; Drug Resistance, Multiple; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Heterocyclic Compounds, 1-Ring; Humans; Meropenem; Sisomicin; Tazobactam; Tetracyclines | 2021 |
Clinical Pharmacokinetics and Pharmacodynamics of Cefiderocol.
Topics: Anti-Bacterial Agents; Cefiderocol; Cephalosporins; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests | 2021 |
Cefiderocol: A Review in Serious Gram-Negative Bacterial Infections.
Topics: Anti-Bacterial Agents; Cefiderocol; Cephalosporins; Double-Blind Method; Drug Resistance, Bacterial; Gram-Negative Bacterial Infections; Healthcare-Associated Pneumonia; Humans; Randomized Controlled Trials as Topic; Urinary Tract Infections | 2021 |
[Clinical aspects of severe infections caused by antibiotic-resistant Gram-negative bacteria. The Empire strikes back?]
Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Ceftazidime; Cephalosporins; Drug Combinations; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacterial Infections; Humans; Penicillanic Acid; Tazobactam | 2017 |
Cefiderocol: a novel siderophore cephalosporin.
Topics: Anti-Bacterial Agents; Cefiderocol; Cephalosporins; Drug Delivery Systems; Drug Design; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Siderophores | 2018 |
Ceftazidime/Avibactam and Ceftolozane/Tazobactam: Novel Therapy for Multidrug Resistant Gram Negative Infections in Children.
Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Ceftazidime; Cephalosporins; Child; Drug Combinations; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacterial Infections; Humans; Penicillanic Acid; Tazobactam; Treatment Outcome | 2018 |
Ceftazidime-Avibactam: A Review in the Treatment of Serious Gram-Negative Bacterial Infections.
Topics: Anti-Bacterial Agents; Azabicyclo Compounds; beta-Lactamase Inhibitors; beta-Lactamases; Ceftazidime; Cephalosporins; Drug Approval; Drug Combinations; Drug Resistance, Multiple, Bacterial; Europe; Gram-Negative Bacterial Infections; Humans; United States | 2018 |
Review on the Characteristic, Properties and Analytical Methods of Cefquinomesulphate: ß-lactam Veterinary Drug.
Topics: Animals; Anti-Bacterial Agents; Biological Availability; Cephalosporins; Drug Resistance, Bacterial; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Molecular Structure; Veterinary Drugs | 2020 |
Cefiderocol: A Siderophore Cephalosporin with Activity Against Carbapenem-Resistant and Multidrug-Resistant Gram-Negative Bacilli.
Topics: Animals; Anti-Bacterial Agents; Azabicyclo Compounds; beta-Lactamase Inhibitors; Carbapenems; Cefiderocol; Ceftazidime; Cephalosporins; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Combinations; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Meropenem; Molecular Structure; Randomized Controlled Trials as Topic; Siderophores | 2019 |
Defining the Role of Novel β-Lactam Agents That Target Carbapenem-Resistant Gram-Negative Organisms.
Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Aztreonam; Boronic Acids; Carbapenems; Cefiderocol; Ceftazidime; Cephalosporins; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Heterocyclic Compounds, 1-Ring; Meropenem; Tazobactam | 2019 |
Ceftolozane/tazobactam: a novel cephalosporin/β-lactamase inhibitor combination with activity against multidrug-resistant gram-negative bacilli.
Topics: Animals; Anti-Bacterial Agents; Cephalosporins; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Gram-Negative Bacterial Infections; Humans; Penicillanic Acid; Tazobactam | 2014 |
Cephalosporins currently in early clinical trials for the treatment of bacterial infections.
Topics: Animals; Anti-Bacterial Agents; Cephalosporins; Clinical Trials as Topic; Cross Infection; Drug Approval; Drug Design; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans | 2014 |
Ceftolozane/tazobactam for the treatment of complicated intra-abdominal infections.
Topics: Anti-Bacterial Agents; Cephalosporins; Clinical Trials, Phase III as Topic; Drug Combinations; Drug Resistance, Bacterial; Gram-Negative Bacterial Infections; Humans; Intraabdominal Infections; Penicillanic Acid; Tazobactam | 2015 |
Achromobacter respiratory infections.
Topics: Achromobacter; Age Factors; Anti-Bacterial Agents; Bronchiectasis; Cefoperazone; Cephalosporins; Community-Acquired Infections; Comorbidity; Drug Resistance, Bacterial; Female; Gram-Negative Bacterial Infections; Humans; Male; Neoplasms; Penicillins; Piperacillin; Pneumonia, Bacterial; Respiratory Tract Infections; Risk Factors; Sex Factors; Ticarcillin; Virulence Factors | 2015 |
Ceftolozane/tazobactam and ceftazidime/avibactam: two novel β-lactam/β-lactamase inhibitor combination agents for the treatment of resistant Gram-negative bacterial infections.
Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Ceftazidime; Cephalosporins; Clinical Trials as Topic; Drug Combinations; Drug Resistance, Bacterial; Enzyme Inhibitors; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Penicillanic Acid; Tazobactam | 2015 |
Treatment options for extended-spectrum beta-lactamase (ESBL) and AmpC-producing bacteria.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Cefepime; Cephalosporins; Drug Resistance, Bacterial; Drug Therapy, Combination; Enterobacteriaceae; Enterobacteriaceae Infections; Gram-Negative Aerobic Bacteria; Gram-Negative Bacterial Infections; Humans; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination | 2016 |
Ceftazidime-Avibactam: A Novel Cephalosporin/β-Lactamase Inhibitor Combination for the Treatment of Resistant Gram-negative Organisms.
Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; Ceftazidime; Cephalosporins; Drug Combinations; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans | 2016 |
Multidrug-resistant oral Capnocytophaga gingivalis responsible for an acute exacerbation of chronic obstructive pulmonary disease: Case report and literature review.
Topics: Aged; Anti-Bacterial Agents; Capnocytophaga; Cephalosporins; DNA Gyrase; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Gene Expression; Gram-Negative Bacterial Infections; Humans; Lincosamides; Macrolides; Male; Mutation; Pulmonary Disease, Chronic Obstructive; Streptogramins | 2016 |
[Diagnostic and therapeutic management of Gram-negative infections].
Topics: Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Cross Infection; Disease Management; Drug Resistance, Multiple, Bacterial; Drug Synergism; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Intensive Care Units; Italy; Pneumonia, Bacterial; Pseudomonas aeruginosa; Pseudomonas Infections | 2008 |
[Broad-spectrum beta-lactamases in Gram-negative bacteria].
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Carbapenems; Cephalosporins; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Monobactams; Penicillins; Plasmids | 2008 |
Ceftobiprole: a novel cephalosporin with activity against Gram-positive and Gram-negative pathogens, including methicillin-resistant Staphylococcus aureus (MRSA).
Topics: Anti-Bacterial Agents; Canada; Cephalosporins; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Methicillin-Resistant Staphylococcus aureus; Treatment Outcome; United States | 2009 |
Ceftobiprole: a new cephalosporin for the treatment of skin and skin structure infections.
Topics: Anti-Bacterial Agents; Cephalosporins; Clinical Trials, Phase III as Topic; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Multicenter Studies as Topic; Skin Diseases, Bacterial; Treatment Outcome | 2009 |
New treatment options against gram-negative organisms.
Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; Carbapenems; Cephalosporins; Drug Resistance, Multiple; Drugs, Investigational; Gram-Negative Bacterial Infections; Humans; United States | 2011 |
β-lactam resistance in gram-negative pathogens isolated from animals.
Topics: Animals; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Cephalosporins; Dogs; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Livestock; Pets; Zoonoses | 2013 |
β-lactamase-mediated resistance: a biochemical, epidemiological and genetic overview.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Cephalosporins; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Penicillins; Point Mutation | 2013 |
[Extended-spectrum of beta-lactamases (ESBL): yesterday ESBL: and today ESBL, carbapenemase-producing and multiresistant bacteria].
Topics: Animals; Anti-Bacterial Agents; Bacterial Infections; Bacterial Proteins; beta-Lactamases; Cephalosporins; Cross Infection; Disinfection; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Gram-Negative Bacterial Infections; Humans; Infant, Newborn | 2012 |
Background and rationale for revised clinical and laboratory standards institute interpretive criteria (Breakpoints) for Enterobacteriaceae and Pseudomonas aeruginosa: I. Cephalosporins and Aztreonam.
Topics: Anti-Bacterial Agents; Aztreonam; Cephalosporins; Enterobacteriaceae; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa | 2013 |
Colonization with antibiotic-resistant Gram-negative bacilli in the neonatal intensive care unit.
Topics: Aminoglycosides; Anti-Bacterial Agents; Cephalosporins; Cross Infection; Disease Outbreaks; Drug Resistance, Bacterial; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Infant, Newborn; Intensive Care Units, Neonatal; Italy; Male; Pregnancy | 2003 |
Cefdinir: a review of its use in the management of mild-to-moderate bacterial infections.
Topics: Anti-Bacterial Agents; Cefdinir; Cephalosporins; Child; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Randomized Controlled Trials as Topic; Treatment Outcome | 2004 |
Treatment of infections with ESBL-producing organisms: pharmacokinetic and pharmacodynamic considerations.
Topics: Animals; Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Drug Resistance; Enterobacteriaceae; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Monte Carlo Method; Treatment Outcome | 2005 |
Resistance in gram-negative bacteria: enterobacteriaceae.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Carbapenems; Cephalosporins; Ciprofloxacin; Community-Acquired Infections; Drug Resistance, Bacterial; Drug Resistance, Multiple; Enterobacteriaceae; Enterobacteriaceae Infections; Gram-Negative Bacterial Infections; Humans; Klebsiella Infections; Quinolones; Urinary Tract Infections | 2006 |
Efficacy and safety of cefepime: a systematic review and meta-analysis.
Topics: Anti-Bacterial Agents; Cefepime; Cephalosporins; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Randomized Controlled Trials as Topic | 2007 |
In-vitro profile of a new beta-lactam, ceftobiprole, with activity against methicillin-resistant Staphylococcus aureus.
Topics: Animals; Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus | 2007 |
Clinical profile of ceftobiprole, a novel beta-lactam antibiotic.
Topics: Anti-Bacterial Agents; Cephalosporins; Clinical Trials as Topic; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Skin Diseases, Bacterial; Staphylococcal Infections; Staphylococcal Skin Infections | 2007 |
Epidemiology of infections caused by multiresistant gram-negatives: ESBLs, MBLs, panresistant strains.
Topics: Aminoglycosides; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cephalosporins; Drug Resistance, Multiple, Bacterial; Europe; Fluoroquinolones; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; North America | 2007 |
Multidrug-resistant Gram-negative bacterial infections: the emerging threat and potential novel treatment options.
Topics: Animals; Carbapenems; Cephalosporins; Clinical Trials as Topic; Drug Resistance, Multiple, Bacterial; Glycylglycine; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Polymyxins | 2008 |
The efficacy and safety of ceftobiprole in the treatment of complicated skin and skin structure infections: evidence from 2 clinical trials.
Topics: Cephalosporins; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Skin Diseases, Bacterial; Treatment Outcome | 2008 |
Ceftobiprole: an extended-spectrum anti-methicillin-resistant Staphylococcus aureus cephalosporin.
Topics: Anti-Bacterial Agents; Cephalosporins; Clinical Trials as Topic; Drug Interactions; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests | 2008 |
Cephalosporin therapeutics for intensive care infections.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacteremia; Cephalosporins; Cross Infection; Drug Resistance, Microbial; Drug Therapy, Combination; Gram-Negative Bacterial Infections; Humans; Intensive Care Units; Severity of Illness Index; Tissue Distribution; Treatment Outcome | 1993 |
Meningitis due to Aeromonas species: case report and review.
Topics: Aeromonas; Cephalosporins; Gram-Negative Bacterial Infections; Humans; Male; Meningitis, Bacterial; Middle Aged | 1993 |
Hospital-acquired infections: diseases with increasingly limited therapies.
Topics: Candidiasis; Cephalosporins; Cross Infection; Drug Resistance, Microbial; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Vancomycin | 1994 |
Review of in vitro activity, pharmacokinetic characteristics, safety, and clinical efficacy of cefprozil, a new oral cephalosporin.
Topics: Administration, Oral; Aged; beta-Lactamases; Cefprozil; Cephalosporins; Child; Child, Preschool; Clinical Trials as Topic; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Infant | 1993 |
[3d generation cephalosporins: clinico-infectiologic evaluation after 10 years].
Topics: Adult; Cephalosporins; Child; Dose-Response Relationship, Drug; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Product Surveillance, Postmarketing | 1993 |
[Slowly-evolving pneumonia in a 14-year-old boy].
Topics: Adolescent; Cefuroxime; Cephalosporins; Drug Resistance, Microbial; Eikenella corrodens; Gram-Negative Bacterial Infections; Humans; Male; Pneumonia, Bacterial | 1995 |
[Cefotaxime (klaforan) in modern therapy of bacterial infections].
Topics: Anti-Bacterial Agents; Blood-Brain Barrier; Cefotaxime; Cephalosporins; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Respiratory Tract Infections | 1996 |
Use of oral cephalosporins in infants and children.
Topics: Administration, Oral; Cephalosporins; Child; Child, Preschool; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Infant; Infant, Newborn; Molecular Structure | 1997 |
[Contribution to the treatment of acute bovine mastitis with cefquinome].
Topics: Animals; Cattle; Cephalosporins; Clinical Trials as Topic; Enterobacteriaceae Infections; Escherichia coli Infections; Female; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Mastitis, Bovine; Multicenter Studies as Topic | 1997 |
[Febrile neutropenia: empiric antibiotic therapy from 1975 to 1997].
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; Cefepime; Ceftazidime; Cephalosporins; Drug Therapy, Combination; Fever; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Imipenem; Meropenem; Neutropenia; Sepsis; Thienamycins | 1997 |
[Aeromonas infections].
Topics: 4-Quinolones; Aeromonas; Age Factors; Aged; Animals; Anti-Infective Agents; Cephalosporins; Fishes; Gastrointestinal Diseases; Gram-Negative Bacterial Infections; Humans; Middle Aged; Seafood | 1997 |
Antimicrobial prophylaxis in orthopaedic surgery: the role of teicoplanin.
Topics: Anti-Bacterial Agents; Arthroplasty, Replacement; Cephalosporins; Clinical Trials as Topic; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Postoperative Complications; Teicoplanin | 1998 |
Infection due to Moraxella osloensis: case report and review of the literature.
Topics: Bacteremia; Cephalosporins; Child, Preschool; Female; Gram-Negative Bacterial Infections; Humans; Male; Moraxella; Neisseriaceae Infections | 2000 |
Fourth generation cephalosporins in the antimicrobial chemotherapy of surgical infections.
Topics: Abdomen; Appendicitis; Cephalosporins; Cross Infection; Female; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Pelvic Inflammatory Disease; Surgical Wound Infection | 1999 |
Treatment options for extended-spectrum beta-lactamase-producers.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamase Inhibitors; beta-Lactamases; Cephalosporins; Drug Combinations; Enzyme Inhibitors; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans | 2000 |
Novel oral cephalosporins.
Topics: Administration, Oral; Cephalosporins; Clinical Trials as Topic; Drugs, Investigational; Gram-Negative Bacterial Infections; Humans | 2000 |
Crossing the envelope: how cephalosporins reach their targets.
Topics: Bacterial Outer Membrane Proteins; beta-Lactam Resistance; beta-Lactamases; Biological Transport; Cell Membrane; Cephalosporins; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans | 2000 |
The final goal: penicillin-binding proteins and the target of cephalosporins.
Topics: Bacterial Proteins; Carrier Proteins; Cephalosporins; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Hexosyltransferases; Humans; Kinetics; Muramoylpentapeptide Carboxypeptidase; Penicillin-Binding Proteins; Peptidyl Transferases; Structure-Activity Relationship | 2000 |
Role of parenteral cephalosporins in community-acquired lower respiratory tract infections.
Topics: Cephalosporins; Community-Acquired Infections; Drug Resistance, Microbial; Gram-Negative Bacterial Infections; Humans; Injections, Intravenous; Italy; Respiratory Tract Infections | 2000 |
Role of long-acting cephalosporins in the treatment of lower respiratory tract infections.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Cefotaxime; Ceftriaxone; Cephalosporins; Female; Gram-Negative Bacterial Infections; Humans; Male; Middle Aged; Randomized Controlled Trials as Topic; Respiratory Tract Infections | 2000 |
The astonishing complexity of antibiotic resistance.
Topics: Cefepime; Cephalosporins; Drug Resistance, Microbial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Porins | 2000 |
Cefuroxime axetil: an updated review of its use in the management of bacterial infections.
Topics: Age Factors; Cefuroxime; Cephalosporins; Clinical Trials as Topic; Economics, Pharmaceutical; Female Urogenital Diseases; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Lyme Disease; Male Urogenital Diseases; Respiratory Tract Infections; Skin Diseases | 2001 |
Effect of antibiotics on polycation-treated Escherichia coli HB101 (pRI203).
Topics: Anti-Bacterial Agents; Cell Membrane; Cephalosporins; Escherichia coli; Gram-Negative Bacterial Infections; Permeability; Plasmids; Polyamines; Polyelectrolytes | 1991 |
Which cephalosporin?
Topics: Bacterial Infections; Cefazolin; Cefoxitin; Cefuroxime; Cephalexin; Cephalosporins; Drug Costs; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans | 1992 |
41 trial(s) available for cephalosporin c and Bacterial Infections, Gram-Negative
| Article | Year |
|---|---|
Investigator-Driven Randomised Controlled Trial of Cefiderocol versus Standard Therapy for Healthcare-Associated and Hospital-Acquired Gram-negative Bloodstream Infection: Study protocol (the GAME CHANGER trial): study protocol for an open-label, randomis
Topics: Adult; Anti-Bacterial Agents; Cefiderocol; Cephalosporins; Delivery of Health Care; Gram-Negative Bacterial Infections; Hospitals; Humans; Microbial Sensitivity Tests; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Sepsis; Standard of Care | 2021 |
Ceftolozane/Tazobactam in Neonates and Young Infants: The Challenges of Collecting Pharmacokinetics and Safety Data in This Vulnerable Patient Population.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Cephalosporins; Child; Clinical Trials as Topic; Drug Resistance, Multiple, Bacterial; Female; Gram-Negative Bacterial Infections; Humans; Infant; Infant, Newborn; Infant, Premature; Injections, Intravenous; Male; Preoperative Care; Tazobactam | 2021 |
Plasma pharmacokinetics of ceftolozane/tazobactam in pediatric patients with cystic fibrosis.
Topics: Administration, Intravenous; Adolescent; Anti-Bacterial Agents; Cephalosporins; Child; Child, Preschool; Cystic Fibrosis; Female; Gram-Negative Bacterial Infections; Humans; Male; Tazobactam | 2020 |
Efficacy and safety of cefiderocol or best available therapy for the treatment of serious infections caused by carbapenem-resistant Gram-negative bacteria (CREDIBLE-CR): a randomised, open-label, multicentre, pathogen-focused, descriptive, phase 3 trial.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Carbapenems; Cefiderocol; Cephalosporins; Drug Resistance, Bacterial; Female; Gram-Negative Bacterial Infections; Humans; Male; Middle Aged; Pneumonia, Bacterial; Sepsis; Urinary Tract Infections; Young Adult | 2021 |
Cefiderocol versus high-dose, extended-infusion meropenem for the treatment of Gram-negative nosocomial pneumonia (APEKS-NP): a randomised, double-blind, phase 3, non-inferiority trial.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Cefiderocol; Cephalosporins; Double-Blind Method; Female; Gram-Negative Bacterial Infections; Healthcare-Associated Pneumonia; Humans; Male; Meropenem; Pneumonia, Bacterial | 2021 |
Population Pharmacokinetic Analysis of Cefiderocol, a Parenteral Siderophore Cephalosporin, in Healthy Subjects, Subjects with Various Degrees of Renal Function, and Patients with Complicated Urinary Tract Infection or Acute Uncomplicated Pyelonephritis.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Body Weight; Case-Control Studies; Cefiderocol; Cephalosporins; Creatinine; Drug Administration Schedule; Female; Glomerular Filtration Rate; Gram-Negative Bacterial Infections; Humans; Male; Middle Aged; Models, Statistical; Pyelonephritis; Renal Insufficiency, Chronic; Severity of Illness Index; Siderophores; Urinary Tract Infections | 2018 |
Pharmacokinetics and Safety of Single Intravenous Doses of Ceftolozane/Tazobactam in Children With Proven or Suspected Gram-Negative Infection.
Topics: Administration, Intravenous; Adolescent; Anti-Bacterial Agents; Cephalosporins; Child; Child, Preschool; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Infant; Infant, Newborn; Intraabdominal Infections; Male; Tazobactam; Urinary Tract Infections | 2018 |
Cefiderocol versus imipenem-cilastatin for the treatment of complicated urinary tract infections caused by Gram-negative uropathogens: a phase 2, randomised, double-blind, non-inferiority trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cefiderocol; Cephalosporins; Cilastatin, Imipenem Drug Combination; Colony Count, Microbial; Double-Blind Method; Drug-Related Side Effects and Adverse Reactions; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Infusions, Intravenous; Male; Middle Aged; Protease Inhibitors; Treatment Outcome; Urinary Tract Infections; Urine; Young Adult | 2018 |
Ceftriaxone and Cefotaxime Have Similar Effects on the Intestinal Microbiota in Human Volunteers Treated by Standard-Dose Regimens.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Cefotaxime; Ceftriaxone; Cephalosporins; Feces; Female; Gastrointestinal Microbiome; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Healthy Volunteers; Humans; Male; Middle Aged; RNA, Ribosomal, 16S; Young Adult | 2019 |
Ceftolozane-tazobactam compared with levofloxacin in the treatment of complicated urinary-tract infections, including pyelonephritis: a randomised, double-blind, phase 3 trial (ASPECT-cUTI).
Topics: Adult; Aged; Anti-Infective Agents, Urinary; Cephalosporins; Double-Blind Method; Drug Administration Schedule; Female; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Infusions, Intravenous; Levofloxacin; Male; Middle Aged; Penicillanic Acid; Pyelonephritis; Tazobactam; Treatment Outcome; Urinary Tract Infections; Young Adult | 2015 |
In vitro activity of ceftobiprole against pathogens from two phase 3 clinical trials of complicated skin and skin structure infections.
Topics: Anti-Bacterial Agents; Cephalosporins; Enterobacteriaceae; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Skin Diseases, Bacterial; Staphylococcus | 2008 |
Randomized clinical trial to evaluate the efficacy of a 5-day ceftiofur hydrochloride intramammary treatment on nonsevere gram-negative clinical mastitis.
Topics: Animals; Anti-Bacterial Agents; Cattle; Cephalosporins; Enterobacteriaceae Infections; Escherichia coli Infections; Female; Gram-Negative Bacterial Infections; Klebsiella Infections; Mammary Glands, Animal; Mastitis, Bovine | 2011 |
Prolonged infusion antibiotics for suspected gram-negative infections in the ICU: a before-after study.
Topics: Aged; Anti-Bacterial Agents; beta-Lactams; Cefepime; Cephalosporins; Cohort Studies; Cross Infection; Drug Administration Schedule; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Hospitals, Teaching; Hospitals, Urban; Humans; Infusions, Intravenous; Intensive Care Units; Length of Stay; Male; Meropenem; Middle Aged; Missouri; Penicillanic Acid; Pilot Projects; Piperacillin; Piperacillin, Tazobactam Drug Combination; Thienamycins | 2013 |
Antibiotic rotation for febrile neutropenic patients with hematological malignancies: clinical significance of antibiotic heterogeneity.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; Cefepime; Cephalosporins; Ciprofloxacin; Drug Administration Schedule; Female; Fever; Gram-Negative Bacterial Infections; Hematologic Neoplasms; Humans; Male; Meropenem; Middle Aged; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Thienamycins | 2013 |
Safety and efficacy of cefepime versus ceftazidime in the treatment of severe infections.
Topics: Adolescent; Aged; Anti-Bacterial Agents; Bacterial Infections; Cefepime; Ceftazidime; Cephalosporins; Female; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Pneumonia, Bacterial; Taiwan; Treatment Outcome; Urinary Tract Infections | 2002 |
Continuous infusion versus intermittent administration of cefepime in patients with Gram-negative bacilli bacteraemia.
Topics: Adult; Area Under Curve; Cefepime; Cephalosporins; Chromatography, High Pressure Liquid; Cross-Over Studies; Drug Administration Schedule; Drug Stability; Female; Gram-Negative Bacterial Infections; Humans; Infusions, Intravenous; Injections, Intravenous; Male; Microbial Sensitivity Tests; Middle Aged; Prospective Studies; Time Factors | 2002 |
Antimicrobial susceptibility of Riemerella anatipestifer isolated from ducks and the efficacy of ceftiofur treatment.
Topics: Animals; Cephalosporins; Drug Resistance, Multiple, Bacterial; Ducks; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Microbial Sensitivity Tests; Poultry Diseases | 2003 |
Comparative effects of ciprofloxacin and ceftazidime on cytokine production in patients with severe sepsis caused by gram-negative bacteria.
Topics: Adult; Aged; Anti-Bacterial Agents; Ceftazidime; Cephalosporins; Ciprofloxacin; Cytokines; Female; Gram-Negative Bacterial Infections; Humans; Interleukins; Male; Middle Aged; Sepsis; Treatment Outcome; Tumor Necrosis Factor-alpha | 2004 |
Chemoprophylactic and bactericidal efficacy of 80 mg gentamicin in a single and once-daily dosing.
Topics: Adult; Amniotic Fluid; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cephalosporins; Cesarean Section; Chorioamnionitis; Endometritis; Endometrium; Female; Fetal Blood; Gentamicins; Gram-Negative Bacterial Infections; Humans; Hymen; Placenta; Pregnancy; Pregnancy Complications, Infectious; Tissue Distribution; Treatment Outcome; Umbilical Cord | 2005 |
Cefepime in critically ill patients: continuous infusion vs. an intermittent dosing regimen.
Topics: Adult; Aged; Amikacin; Anti-Bacterial Agents; Area Under Curve; Cefepime; Cephalosporins; Critical Illness; Drug Therapy, Combination; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Infusions, Intravenous; Injections, Intravenous; Male; Microbial Sensitivity Tests; Middle Aged; Prospective Studies; Time Factors; Treatment Outcome | 2005 |
A randomized, double-blind trial comparing ceftobiprole medocaril with vancomycin plus ceftazidime for the treatment of patients with complicated skin and skin-structure infections.
Topics: Aged; Ceftazidime; Cephalosporins; Double-Blind Method; Drug Therapy, Combination; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Skin Diseases, Bacterial; Treatment Outcome; Vancomycin | 2008 |
The efficacy and safety of ceftobiprole in the treatment of complicated skin and skin structure infections: evidence from 2 clinical trials.
Topics: Cephalosporins; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Skin Diseases, Bacterial; Treatment Outcome | 2008 |
Randomized comparison of cefepime and ceftazidime for treatment of hospitalized patients with gram-negative bacteremia.
Topics: Aged; Bacteremia; Cefepime; Ceftazidime; Cephalosporins; Drug Eruptions; Escherichia coli Infections; Female; Gram-Negative Bacterial Infections; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Prospective Studies; Safety | 1995 |
Cefoperazone monotherapy for serious infections in hospitalized patients--an initial Indian experience.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bacteremia; Cefoperazone; Cephalosporins; Female; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Hospitalization; Humans; India; Injections, Intravenous; Male; Middle Aged; Treatment Outcome | 1995 |
Treatment of acute biliary tract infections with ofloxacin: a randomized, controlled clinical trial.
Topics: Anti-Infective Agents; Bacteremia; Ceftriaxone; Cephalosporins; Cholangitis; Cholecystitis; Escherichia coli Infections; Female; Gram-Negative Bacterial Infections; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Ofloxacin; Phlebitis | 1996 |
Comparison of strategies using cefpirome and ceftazidime for empiric treatment of pneumonia in intensive care patients. The Cefpirome Pneumonia Study Group.
Topics: Adult; Cefpirome; Ceftazidime; Cephalosporins; Critical Care; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Drug Tolerance; Female; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Pneumonia, Bacterial; Prospective Studies; Treatment Outcome | 1998 |
[The evaluation of ceftibuten (Cedax) effectiveness in the prevention of perioperative infections].
Topics: Adult; Ceftibuten; Cephalosporins; Child; Child, Preschool; Female; Gram-Negative Bacterial Infections; Humans; Male; Surgical Wound Infection | 1997 |
Meropenem monotherapy versus combination therapy with ceftazidime and amikacin for empirical treatment of febrile neutropenic patients.
Topics: Adolescent; Adult; Aged; Amikacin; Anti-Bacterial Agents; Bacteremia; Bacterial Infections; Ceftazidime; Cephalosporins; Drug Therapy, Combination; Female; Fever; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Male; Meropenem; Middle Aged; Neutropenia; Thienamycins | 1998 |
[Program of empirical antibacterial therapy of community-acquired pneumonia].
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Agents; Ceftibuten; Cefuroxime; Cephalosporins; Community-Acquired Infections; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Male; Middle Aged; Pefloxacin; Pneumonia, Bacterial; Roxithromycin; Spiramycin | 1998 |
Levofloxacin versus cefuroxime axetil in the treatment of acute exacerbation of chronic bronchitis: results of a randomized, double-blind study.
Topics: Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Bronchitis; Cefuroxime; Cephalosporins; Chronic Disease; Double-Blind Method; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Levofloxacin; Middle Aged; Ofloxacin; Treatment Outcome | 1999 |
[Continuous versus intermittent cefepime infusion in critical care. Preliminary results].
Topics: Bacteremia; Cefepime; Cephalosporins; Critical Care; Drug Administration Schedule; Female; Gram-Negative Bacterial Infections; Humans; Infusions, Intravenous; Length of Stay; Male; Middle Aged | 1999 |
Efficacy and safety of twice daily administration of cefpirome in the empiric treatment of sepsis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bacteremia; Cefpirome; Cephalosporins; Drug Administration Schedule; Female; Follow-Up Studies; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Treatment Outcome | 1999 |
[The results of a multicenter study of the comparative activity of cefepime and other antibiotics against the causative agents of severe hospital infections (the Micromax program)].
Topics: Acute Disease; Anti-Bacterial Agents; Cefepime; Cephalosporins; Cross Infection; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Russia | 1999 |
[The role of cefepime, a 4th-generation cephalosporin, in treating patients with surgical sepsis].
Topics: Adolescent; Adult; Aged; Bacteremia; Cefepime; Cephalosporins; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Middle Aged; Severity of Illness Index; Surgical Wound Infection; Systemic Inflammatory Response Syndrome | 1999 |
Management of fever in neutropenic patients with acute leukemia: current role of ceftazidime plus amikacin as empiric therapy.
Topics: Acute Disease; Adolescent; Adult; Aged; Amikacin; Anti-Bacterial Agents; Ceftazidime; Cephalosporins; Drug Therapy, Combination; Female; Fever; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Leukemia, Myeloid; Male; Middle Aged; Neutropenia; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Treatment Outcome | 2000 |
Intermittent and continuous ceftazidime infusion for critically ill trauma patients.
Topics: Adolescent; Adult; Aged; Ceftazidime; Cephalosporins; Chi-Square Distribution; Critical Illness; Cross Infection; Drug Administration Schedule; Female; Follow-Up Studies; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Infusions, Intravenous; Male; Microbial Sensitivity Tests; Middle Aged; Pneumonia, Bacterial; Probability; Treatment Outcome; Wounds and Injuries | 2000 |
Meropenem versus ceftazidime in the treatment of cancer patients with febrile neutropenia: a randomized, double-blind trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Ceftazidime; Cephalosporins; Double-Blind Method; Female; Fever; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Male; Meropenem; Middle Aged; Neoplasms; Neutropenia; Prospective Studies; Thienamycins | 2000 |
[Multicentre, randomized, prospective and comparative study of ceftriaxone, cefotaxime and cefuroxime in treating mild to moderate respiratory tract infection].
Topics: Adolescent; Adult; Aged; Bronchitis; Cefotaxime; Ceftriaxone; Cefuroxime; Cephalosporins; Female; Gram-Negative Bacterial Infections; Humans; Injections, Intravenous; Male; Middle Aged; Pneumonia; Prospective Studies | 1998 |
[Cefepime in the treatment of osteomyelitis caused by Gram negative bacilli].
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Cefepime; Cephalosporins; Chronic Disease; Female; Gram-Negative Bacterial Infections; Humans; Male; Middle Aged; Osteomyelitis; Patient Selection | 2000 |
Evaluation of endotoxin release and cytokine production induced by antibiotics in patients with Gram-negative nosocomial pneumonia.
Topics: Anti-Bacterial Agents; Ceftazidime; Cephalosporins; Cross Infection; Cytokines; Female; Gram-Negative Bacterial Infections; Humans; Imipenem; Interleukin-1; Interleukin-6; Lipopolysaccharides; Male; Middle Aged; Pneumonia, Bacterial; Prospective Studies; Sepsis; Statistics, Nonparametric; Thienamycins; Tumor Necrosis Factor-alpha | 2002 |
Cefpirome versus ceftazidime in the treatment of urinary tract infections.
Topics: Cefpirome; Ceftazidime; Cephalosporins; Drug Administration Schedule; Female; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Infusions, Intravenous; Injections, Intravenous; Male; Middle Aged; Urinary Tract Infections | 1992 |
235 other study(ies) available for cephalosporin c and Bacterial Infections, Gram-Negative
| Article | Year |
|---|---|
The tension between clinical and microbiological relevance in applying clinical trial results for Gram negative bacterial infections.
Topics: Cephalosporins; Gram-Negative Bacterial Infections; Humans | 2021 |
Higher incidence of prescribing rates and utilization of broad spectrum cephalosporin in young patients: A retrospective observational study in a tertiary care hospital.
Topics: Adolescent; Adult; Age Factors; Cephalosporins; Child; Female; Gram-Negative Bacterial Infections; Humans; Male; Meningitis; Microbial Sensitivity Tests; Practice Patterns, Physicians'; Respiratory Tract Infections; Retrospective Studies; Tertiary Care Centers; Urinary Tract Infections | 2021 |
[Third-generation cephalosporins programmed restriction in the context of an outbreak of AmpC β-lactamase-producing gram-negative bacilli in critical units: a real-life experience].
Topics: Adult; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Cephalosporins; Disease Outbreaks; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans | 2021 |
Successful treatment of MDR Stenotrophomonas maltophilia-associated pneumonia with cefiderocol-based regimen in a patient with hematological malignancy.
Topics: Anti-Bacterial Agents; Cefiderocol; Cephalosporins; Gram-Negative Bacterial Infections; Hematologic Neoplasms; Humans; Pneumonia; Stenotrophomonas maltophilia | 2022 |
Acquisition of extended-spectrum cephalosporin-resistant Gram-negative bacteria: epidemiology and risk factors in a 6-year cohort of 507 severe trauma patients.
Topics: Anti-Bacterial Agents; Cephalosporins; Cohort Studies; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Monobactams; Retrospective Studies; Risk Factors | 2022 |
Real-world clinical outcome of cefiderocol for treatment of multidrug-resistant non-fermenting, gram negative bacilli infections: a case series.
Topics: Anti-Bacterial Agents; Cefiderocol; Cephalosporins; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests | 2023 |
Re: 'Real world clinical outcome of cefiderocol for treatment of multidrug-resistant nonfermenting gram-negative bacilli infections' by Hoellinger et al.
Topics: Anti-Bacterial Agents; Cefiderocol; Cephalosporins; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests | 2023 |
[Cefiderocol in AML patient with neutropenic infection due to 4MRGN Klebsiella pneumoniae (VIM-1)].
Topics: Aged; Anti-Bacterial Agents; Azabicyclo Compounds; beta-Lactamases; Cefiderocol; Ceftazidime; Cephalosporins; Colistin; Communicable Diseases; Drug Combinations; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Neoplasm Recurrence, Local; Neutropenia | 2023 |
Re: real world clinical outcome of cefiderocol for treatment of multidrug-resistant non-fermenting gram-negative bacilli infections: author's response.
Topics: Anti-Bacterial Agents; Cefiderocol; Cephalosporins; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests | 2023 |
Real-life use of cefiderocol for salvage therapy of severe infections due to carbapenem-resistant Gram-negative bacteria.
Topics: Anti-Bacterial Agents; Carbapenems; Cefiderocol; Cephalosporins; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Retrospective Studies; Salvage Therapy | 2023 |
Risk factors for colonization with multidrug-resistant Gram-negative bacteria and
Topics: Anti-Bacterial Agents; Carbapenems; Cephalosporins; Clostridioides; Clostridioides difficile; Drug Resistance, Multiple, Bacterial; Escherichia coli; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Long-Term Care; Prevalence; Risk Factors | 2023 |
High Burden of Intestinal Colonization With Antimicrobial-Resistant Bacteria in Chile: An Antibiotic Resistance in Communities and Hospitals (ARCH) Study.
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Bacteria; Carbapenems; Cephalosporins; Chile; COVID-19; Drug Resistance, Microbial; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Hospitals; Humans; Risk Factors | 2023 |
Cefiderocol use for the treatment of infections by carbapenem-resistant Gram-negative bacteria: an Italian multicentre real-life experience.
Topics: Acinetobacter Infections; Aged; Anti-Bacterial Agents; Carbapenems; Cefiderocol; Cephalosporins; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Male; Retrospective Studies | 2023 |
Strong correlation between the rates of intrinsically antibiotic-resistant species and the rates of acquired resistance in Gram-negative species causing bacteraemia, EU/EEA, 2016.
Topics: Acinetobacter; Anti-Bacterial Agents; Bacteremia; Carbapenems; Cephalosporins; Drug Resistance, Bacterial; Escherichia coli; Europe; European Union; Fluoroquinolones; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Sentinel Surveillance | 2019 |
Efficacy of newer β lactams/ β lactamase inhibitors for treatment of multidrug resistant gram negative infections in burn patients.
Topics: Acinetobacter baumannii; beta-Lactam Resistance; beta-Lactamase Inhibitors; beta-Lactams; Burns; Carbapenem-Resistant Enterobacteriaceae; Cephalosporins; Drug Combinations; Drug Development; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacterial Infections; Humans; Pseudomonas aeruginosa | 2019 |
In vitro evidence of the synergistic interaction of ceftopibrole and other antibiotics against multidrug-resistant Gram-negative isolates.
Topics: Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Drug Resistance, Multiple, Bacterial; Drug Synergism; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Microbial Viability | 2019 |
Comparison of ceftazidime-avibactam and ceftolozane-tazobactam in vitro activities when tested against gram-negative bacteria isolated from patients hospitalized with pneumonia in United States medical centers (2017-2018).
Topics: Academic Medical Centers; Anti-Bacterial Agents; Azabicyclo Compounds; Ceftazidime; Cephalosporins; Drug Combinations; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Pneumonia, Bacterial; Tazobactam; United States | 2020 |
In Vitro Activity of Cefiderocol, a Novel Siderophore Cephalosporin, against Gram-Negative Bacilli Isolated from Patients in Canadian Intensive Care Units.
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Canada; Carbapenems; Cefiderocol; Cephalosporins; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Intensive Care Units; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Siderophores; Stenotrophomonas maltophilia | 2020 |
Association between the rate of fluoroquinolones-resistant gram-negative bacteria and antibiotic consumption from China based on 145 tertiary hospitals data in 2014.
Topics: Anti-Bacterial Agents; Carbapenems; Cephalosporins; China; Cross-Sectional Studies; Drug Resistance, Bacterial; Drug Utilization; Fluoroquinolones; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Penicillins; Retrospective Studies; Tertiary Care Centers | 2020 |
Evaluation of ultra-rapid susceptibility testing of ceftolozane-tazobactam by a flow cytometry assay directly from positive blood cultures.
Topics: Anti-Bacterial Agents; Blood Culture; Cephalosporins; Flow Cytometry; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Portugal; Spain; Tazobactam | 2020 |
A highly multiplexed melt-curve assay for detecting the most prevalent carbapenemase, ESBL, and AmpC genes.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Cephalosporins; Drug Resistance, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Molecular Diagnostic Techniques; Multiplex Polymerase Chain Reaction; Sensitivity and Specificity | 2020 |
Combining bacteriophages with cefiderocol and meropenem/vaborbactam to treat a pan-drug resistant Achromobacter species infection in a pediatric cystic fibrosis patient.
Topics: Achromobacter; Anti-Bacterial Agents; Bacteriophages; Boronic Acids; Cefiderocol; Cephalosporins; Child; Combined Modality Therapy; Cystic Fibrosis; Drug Combinations; Drug Resistance, Bacterial; Drug Resistance, Multiple; Female; Gram-Negative Bacterial Infections; Heterocyclic Compounds, 1-Ring; Humans; Meropenem | 2020 |
Activity of ceftolozane/tazobactam against commonly encountered antimicrobial resistant Gram-negative bacteria in Lebanon.
Topics: Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Drug Resistance, Multiple, Bacterial; Escherichia coli; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Klebsiella pneumoniae; Lebanon; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Tazobactam | 2020 |
Cefiderocol Retains Antibiofilm Activity in Multidrug-Resistant Gram-Negative Pathogens.
Topics: Anti-Bacterial Agents; Biofilms; Cefiderocol; Cephalosporins; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa | 2021 |
Cefiderocol for the Treatment of Adult and Pediatric Patients With Cystic Fibrosis and Achromobacter xylosoxidans Infections.
Topics: Achromobacter denitrificans; Adult; Anti-Bacterial Agents; Cefiderocol; Cephalosporins; Child; Cystic Fibrosis; Gram-Negative Bacterial Infections; Humans | 2021 |
Serious adverse events with novel beta-lactam/beta-lactamase inhibitor combinations: a large-scale pharmacovigilance analysis.
Topics: Adult; Aged; Aged, 80 and over; Agranulocytosis; Anti-Bacterial Agents; Azabicyclo Compounds; beta-Lactamase Inhibitors; Ceftazidime; Cephalosporins; Drug Combinations; Drug Therapy, Combination; Female; Gram-Negative Bacterial Infections; Humans; Lactams; Male; Microbial Sensitivity Tests; Middle Aged; Pancytopenia; Pharmacovigilance; Retrospective Studies; Tazobactam | 2021 |
Susceptibility trends of ceftolozane/tazobactam and comparators when tested against U.S. gram-negative bacterial surveillance isolates (2012-2018).
Topics: Anti-Bacterial Agents; Cephalosporins; Drug Resistance, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Public Health Surveillance; Tazobactam; United States | 2021 |
Cefiderocol: a novel siderophore cephalosporin for multidrug-resistant Gram-negative bacterial infections.
Topics: Anti-Bacterial Agents; Cefiderocol; Cephalosporins; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Siderophores | 2021 |
Cefepime/tazobactam compared with other tazobactam combinations against problem Gram-negative bacteria.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Cefepime; Cephalosporins; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Tazobactam | 2021 |
The place of ceftazidime/avibactam and ceftolozane/tazobactam for therapy of haematological patients with febrile neutropenia.
Topics: Adult; Aged; Allografts; Anti-Bacterial Agents; Autografts; Azabicyclo Compounds; Bacteremia; Carbapenems; Ceftazidime; Cephalosporins; Drug Combinations; Drug Resistance, Multiple, Bacterial; Febrile Neutropenia; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Male; Middle Aged; Retrospective Studies; Tazobactam; Treatment Outcome; Young Adult | 2021 |
Evaluation of a Novel Culture System for Rapid Pathogen Identification and Detection of Cephalosporin Resistance in Neonatal Gram-negative Sepsis at a Tertiary Referral Unit in Harare, Zimbabwe.
Topics: Adult; Bacterial Load; Blood Culture; Cephalosporin Resistance; Cephalosporins; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Infant, Newborn; Male; Microbiological Techniques; Mothers; Neonatal Sepsis; Zimbabwe | 2021 |
Trends and correlation between antibacterial consumption and carbapenem resistance in gram-negative bacteria in a tertiary hospital in China from 2012 to 2019.
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; beta-Lactamase Inhibitors; Burkholderia cepacia; Carbapenems; Cephalosporins; China; Drug Resistance, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Linear Models; Microbial Sensitivity Tests; Retrospective Studies; Tertiary Care Centers; Tetracyclines | 2021 |
A rapid and inexpensive protocol to screen for third generation cephalosporin-resistant and non-fermenting Gram-negative rods directly in positive blood cultures.
Topics: Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; beta-Lactamases; Blood Culture; Cephalosporin Resistance; Cephalosporins; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Oxidoreductases; Prospective Studies; Sensitivity and Specificity | 2021 |
Optimised cefiderocol exposures in a successfully treated critically ill patient with polymicrobial Stenotrophomonas maltophilia bacteraemia and pneumonia receiving continuous venovenous haemodiafiltration.
Topics: Anti-Bacterial Agents; Cefiderocol; Cephalosporins; Coinfection; Continuous Renal Replacement Therapy; Critical Illness; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacterial Infections; Humans; Male; Middle Aged; Pneumonia; Stenotrophomonas maltophilia | 2021 |
Optimization of antibiotics for cystic fibrosis pulmonary exacerbations due to highly resistant nonlactose fermenting Gram negative bacilli: Meropenem-vaborbactam and cefiderocol.
Topics: Anti-Bacterial Agents; Boronic Acids; Cefiderocol; Cephalosporins; Child; Cystic Fibrosis; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Meropenem | 2021 |
Prevalence and risk factors for antimicrobial resistance among newborns with gram-negative sepsis.
Topics: Ampicillin; Anti-Bacterial Agents; Cephalosporins; Drug Resistance, Multiple, Bacterial; Ethiopia; Female; Gentamicins; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Infant, Newborn; Male; Microbial Viability; Neonatal Sepsis; Penicillin G; Pregnancy; Prevalence; Tertiary Care Centers | 2021 |
Activity of cefiderocol (S-649266) against carbapenem-resistant Gram-negative bacteria collected from inpatients in Greek hospitals.
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cefepime; Cefiderocol; Ceftazidime; Cephalosporins; Colistin; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Greece; Humans; Inpatients; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Minocycline; Pseudomonas aeruginosa; Thienamycins; Tigecycline | 2017 |
Activity of ceftolozane/tazobactam against surveillance and 'problem' Enterobacteriaceae, Pseudomonas aeruginosa and non-fermenters from the British Isles.
Topics: Anti-Infective Agents; beta-Lactamase Inhibitors; Cephalosporins; Epidemiological Monitoring; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Polymerase Chain Reaction; Tazobactam; United Kingdom | 2017 |
Cost-effectiveness of ceftolozane/tazobactam plus metronidazole compared with piperacillin/tazobactam as empiric therapy for the treatment of complicated intra-abdominal infections based on the in-vitro surveillance of bacterial isolates in the UK.
Topics: Anti-Bacterial Agents; Bacteriological Techniques; Cephalosporins; Clinical Protocols; Drug Combinations; Drug Therapy, Combination; Female; Gram-Negative Bacterial Infections; Humans; Intraabdominal Infections; Male; Metronidazole; Models, Econometric; Monte Carlo Method; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Quality-Adjusted Life Years; Tazobactam; United Kingdom | 2017 |
Determination of Disk Diffusion and MIC Quality Control Guidelines for High-Dose Cefepime-Tazobactam (WCK 4282), a Novel Antibacterial Combination Consisting of a β-Lactamase Inhibitor and a Fourth-Generation Cephalosporin.
Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; Cefepime; Cephalosporins; Disk Diffusion Antimicrobial Tests; Drug Combinations; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Guidelines as Topic; Humans; Penicillanic Acid; Quality Control; Tazobactam | 2017 |
Clinical Outcomes in Patients With Gram-Negative Infections Treated With Optimized Dosing Cefepime Over Various Minimum Inhibitory Concentrations.
Topics: Adult; Aged; Anti-Bacterial Agents; Cefepime; Cephalosporins; Cohort Studies; Dose-Response Relationship, Drug; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Gram-Negative Bacterial Infections; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Treatment Outcome | 2018 |
[Urosepsis].
Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cephalosporins; Fluoroquinolones; Gram-Negative Bacterial Infections; Humans; Sepsis; Urinary Tract Infections | 2018 |
[Urosepsis].
Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cephalosporins; Fluoroquinolones; Gram-Negative Bacterial Infections; Humans; Sepsis; Urinary Tract Infections | 2018 |
Pyonephrosis by Lelliottia amnigena.
Topics: Cephalosporins; Gram-Negative Anaerobic Bacteria; Gram-Negative Bacterial Infections; Humans; Male; Middle Aged; Pyonephrosis | 2018 |
Antibacterial effect of ceftolozane/tazobactam in combination with amikacin against aerobic Gram-negative bacilli studied in an in vitro pharmacokinetic model of infection.
Topics: Amikacin; Anti-Bacterial Agents; Bacterial Load; beta-Lactamase Inhibitors; Cephalosporins; Drug Therapy, Combination; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Meropenem; Microbial Sensitivity Tests; Microbial Viability; Models, Theoretical; Tazobactam | 2018 |
Impact of an infectious diseases specialist-led antimicrobial stewardship programmes on antibiotic use and antimicrobial resistance in a large Korean hospital.
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Antimicrobial Stewardship; Carbapenems; Cephalosporins; Drug Prescriptions; Drug Resistance, Multiple, Bacterial; Enterococcus faecium; Escherichia coli; Fluoroquinolones; Glycopeptides; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Hospital Mortality; Hospitals; Humans; Intensive Care Units; Klebsiella pneumoniae; Physicians; Pseudomonas aeruginosa; Republic of Korea; Specialization; Staphylococcus aureus | 2018 |
Know your enemy: managing resistant Gram-negative infections.
Topics: Animals; Antimicrobial Stewardship; Azabicyclo Compounds; Carrier State; Ceftazidime; Cephalosporins; Drug Combinations; Drug Development; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Tazobactam | 2018 |
In Vitro Activities of Ceftaroline/Avibactam, Ceftazidime/Avibactam, and Other Comparators Against Pathogens From Various Complicated Infections in China.
Topics: Acinetobacter; Anti-Bacterial Agents; Azabicyclo Compounds; Ceftaroline; Ceftazidime; Cephalosporins; China; Drug Combinations; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Hospitalization; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Public Health Surveillance | 2018 |
In Vitro Activity of Cefiderocol, a Siderophore Cephalosporin, Against Gram-Negative Bacilli Isolated by Clinical Laboratories in North America and Europe in 2015-2016: SIDERO-WT-2015.
Topics: Acinetobacter; Anti-Bacterial Agents; Burkholderia cepacia; Cefiderocol; Cephalosporins; Drug Resistance, Multiple, Bacterial; Europe; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; North America; Pseudomonas aeruginosa; Siderophores; Stenotrophomonas maltophilia | 2019 |
Association between antibiotic consumption and the rate of carbapenem-resistant Gram-negative bacteria from China based on 153 tertiary hospitals data in 2014.
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cephalosporins; China; Drug Resistance, Bacterial; Drug Utilization; Escherichia coli; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Klebsiella pneumoniae; Penicillins; Prevalence; Pseudomonas aeruginosa; Quinolones; Retrospective Studies; Tertiary Care Centers | 2018 |
Novel Antibiotics in the Treatment of Urinary Tract Infections.
Topics: Aminoglycosides; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Carbapenems; Cephalosporins; Clinical Trials as Topic; Cystitis; Drug Resistance, Bacterial; Drug Therapy, Combination; Drug Utilization; Fluoroquinolones; Gram-Negative Bacterial Infections; Humans; Iatrogenic Disease; Tetracyclines; Urinary Tract Infections | 2019 |
Activity of ceftolozane-tazobactam and comparators when tested against Gram-negative isolates collected from paediatric patients in the USA and Europe between 2012 and 2016 as part of a global surveillance programme.
Topics: Adolescent; Anti-Bacterial Agents; beta-Lactamase Inhibitors; Cephalosporins; Child; Child, Preschool; Europe; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Hospitals; Humans; Infant; Infant, Newborn; Male; Microbial Sensitivity Tests; Prospective Studies; Tazobactam; United States | 2019 |
Ceftobiprole activity when tested against contemporary bacteria causing bloodstream infections in the United States (2016-2017).
Topics: Anti-Bacterial Agents; Bacteremia; Cephalosporins; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; United States | 2019 |
Cefiderocol: a promising antibiotic against multidrug-resistant Gram-negative bacteria.
Topics: Animals; Anti-Bacterial Agents; Cefiderocol; Cephalosporins; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans | 2019 |
Distribution of
Topics: Adolescent; Adult; Aged; Aged, 80 and over; beta-Lactamases; Cephalosporins; Child; Child, Preschool; Cross Infection; Cross-Sectional Studies; Escherichia coli Proteins; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Infant; Male; Microbial Sensitivity Tests; Middle Aged; Pakistan; Plasmids; Tertiary Care Centers; Young Adult | 2019 |
Faecal carriage of ESBL-producing Enterobacteriaceae and carbapenem-resistant Gram-negative bacilli in community settings.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Argentina; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Carrier State; Cephalosporins; Child; Child, Preschool; Community-Acquired Infections; Feces; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Infant; Male; Microbial Sensitivity Tests; Middle Aged; Prevalence; Young Adult | 2013 |
In vitro activity of ceftaroline-avibactam against gram-negative and gram-positive pathogens isolated from patients in Canadian hospitals from 2010 to 2012: results from the CANWARD surveillance study.
Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Canada; Ceftaroline; Cephalosporins; Cross Infection; Drug Resistance, Multiple, Bacterial; Drug Synergism; Drug Therapy, Combination; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Public Health Surveillance; Retrospective Studies | 2013 |
In vivo efficacy of humanized ceftaroline fosamil-avibactam exposures in a polymicrobial infection model.
Topics: Animals; Anti-Bacterial Agents; Azabicyclo Compounds; Bacteroides fragilis; Ceftaroline; Cephalosporins; Coinfection; Drug Administration Schedule; Drug Combinations; Enterobacter cloacae; Escherichia coli; Female; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Immunocompromised Host; Methicillin-Resistant Staphylococcus aureus; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Treatment Outcome | 2013 |
Evaluation of Ertapenem use with impact assessment on extended-spectrum beta-lactamases (ESBL) production and gram-negative resistance in Singapore General Hospital (SGH).
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Carbapenems; Cephalosporins; Child; Child, Preschool; Drug Resistance, Multiple, Bacterial; Ertapenem; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Hospitals, General; Humans; Imipenem; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Singapore; Thienamycins; Young Adult | 2013 |
Activity of ceftolozane-tazobactam against a broad spectrum of recent clinical anaerobic isolates.
Topics: Anaerobiosis; Anti-Bacterial Agents; Bacteroides fragilis; Cephalosporins; Clostridium; Drug Combinations; Fusobacterium; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Prevotella; Propionibacterium; Tazobactam | 2014 |
Non-cephalosporin-susceptible, glucose non-fermentative Gram-negative bacilli meningitis in post-neurosurgical adults: clinical characteristics and therapeutic outcome.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Cephalosporins; Fermentation; Glucose; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Meningitis, Bacterial; Microbial Sensitivity Tests; Middle Aged; Surgical Wound Infection; Young Adult | 2014 |
Bacteremia and empyema caused by Shewanella algae in a trauma patient.
Topics: Adult; Bacteremia; Cephalosporins; Empyema, Pleural; Gram-Negative Bacterial Infections; Humans; Lung Injury; Male; Shewanella; Wounds, Gunshot | 2014 |
Effect of cefepime dose on mortality of patients with Gram-negative bacterial bloodstream infections: a prospective cohort study.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; Cefepime; Cephalosporins; Drug Resistance, Bacterial; Drug Substitution; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Hospital Mortality; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Prospective Studies; Risk Factors; Treatment Outcome | 2014 |
Ceftolozane/tazobactam activity tested against Gram-negative bacterial isolates from hospitalised patients with pneumonia in US and European medical centres (2012).
Topics: Academic Medical Centers; Anti-Bacterial Agents; Cephalosporins; Cross Infection; Europe; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Pneumonia, Bacterial; Tazobactam; United States | 2014 |
Achromobacter buckle infection diagnosed by a 16S rDNA clone library analysis: a case report.
Topics: Achromobacter; Anti-Bacterial Agents; Betamethasone; Cefdinir; Cephalosporins; Device Removal; DNA, Bacterial; DNA, Ribosomal; Drug Therapy, Combination; Eye Infections, Bacterial; Female; Fluoroquinolones; Glucocorticoids; Gram-Negative Bacterial Infections; Humans; Middle Aged; Moxifloxacin; Polymerase Chain Reaction; Prosthesis-Related Infections; Retinal Detachment; RNA, Ribosomal, 16S; Scleral Buckling | 2014 |
[Antimicrobial properties of ceftaroline fosamil].
Topics: Ceftaroline; Ceftriaxone; Cephalosporins; Community-Acquired Infections; Cross Infection; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests | 2014 |
Ceftolozane/tazobactam for the treatment of complicated urinary tract and intra-abdominal infections.
Topics: Animals; beta-Lactamase Inhibitors; Cephalosporins; Clinical Trials as Topic; Enterobacteriaceae; Escherichia coli; Gram-Negative Bacterial Infections; Humans; Intraabdominal Infections; Investigational New Drug Application; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Penicillanic Acid; Pseudomonas aeruginosa; Tazobactam; Treatment Outcome; Urinary Tract Infections | 2015 |
Third generation cephalosporin resistant Enterobacteriaceae and multidrug resistant gram-negative bacteria causing bacteremia in febrile neutropenia adult cancer patients in Lebanon, broad spectrum antibiotics use as a major risk factor, and correlation w
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Antineoplastic Agents; Bacteremia; Cephalosporins; Child; Child, Preschool; Drug Resistance, Bacterial; Enterobacteriaceae; Febrile Neutropenia; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Lebanon; Male; Middle Aged; Neoplasms; Prognosis; Retrospective Studies; Young Adult | 2015 |
Evaluation of clinical outcomes in patients with Gram-negative bloodstream infections according to cefepime MIC.
Topics: Adult; Aged; Aged, 80 and over; Bacteremia; Cefepime; Cephalosporins; Cohort Studies; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Length of Stay; Male; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Survival Analysis; Treatment Outcome | 2015 |
A new ASPECT for complicated urinary tract infections.
Topics: Anti-Infective Agents, Urinary; Cephalosporins; Female; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Levofloxacin; Male; Penicillanic Acid; Urinary Tract Infections | 2015 |
Clinical outcomes following hospital-wide implementation of prolonged-infusion cefepime and ceftazidime.
Topics: Adult; Anti-Bacterial Agents; Cefepime; Ceftazidime; Cephalosporins; Gram-Negative Bacterial Infections; Hospitals; Humans; Infusions, Intravenous; Retrospective Studies; Survival Analysis; Time Factors; Treatment Outcome | 2015 |
Infection: Ceftolozane-tazobactam gives a new ASPECT to the fight against antimicrobial resistance.
Topics: Anti-Infective Agents, Urinary; Cephalosporins; Female; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Levofloxacin; Male; Penicillanic Acid; Urinary Tract Infections | 2015 |
Cefepime and Ceftazidime Safety in Hospitalized Infants.
Topics: Anti-Bacterial Agents; Cefepime; Ceftazidime; Cephalosporins; Drug-Related Side Effects and Adverse Reactions; Gram-Negative Bacterial Infections; Hospitalization; Humans; Infant; Infant, Newborn; Seizures; Survival Analysis | 2015 |
Ceftolozane-tazobactam versus levofloxacin in urinary tract infection.
Topics: Anti-Infective Agents, Urinary; Cephalosporins; Female; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Levofloxacin; Male; Penicillanic Acid; Urinary Tract Infections | 2015 |
Ceftolozane-tazobactam versus levofloxacin in urinary tract infection.
Topics: Anti-Infective Agents, Urinary; Cephalosporins; Female; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Levofloxacin; Male; Penicillanic Acid; Urinary Tract Infections | 2015 |
Ceftolozane-tazobactam versus levofloxacin in urinary tract infection.
Topics: Anti-Infective Agents, Urinary; Cephalosporins; Female; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Levofloxacin; Male; Penicillanic Acid; Urinary Tract Infections | 2015 |
Ceftolozane-tazobactam versus levofloxacin in urinary tract infection - Authors' reply.
Topics: Anti-Infective Agents, Urinary; Cephalosporins; Female; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Levofloxacin; Male; Penicillanic Acid; Urinary Tract Infections | 2015 |
Defining Clinical Exposures of Cefepime for Gram-Negative Bloodstream Infections That Are Associated with Improved Survival.
Topics: Adult; Aged; Anti-Bacterial Agents; APACHE; Cefepime; Cephalosporins; Cohort Studies; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Illinois; Intensive Care Units; Length of Stay; Male; Microbial Sensitivity Tests; Middle Aged; Models, Theoretical; Multivariate Analysis; Patient Readmission; Retrospective Studies; Treatment Outcome | 2015 |
Three-times-weekly, post-dialysis cefepime therapy in patients on maintenance hemodialysis: a retrospective study.
Topics: Aged; Anti-Bacterial Agents; Anuria; Cefepime; Cephalosporins; Cohort Studies; Drug Administration Schedule; Drug Monitoring; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Infusions, Intravenous; Male; Microbial Sensitivity Tests; Middle Aged; Outpatient Clinics, Hospital; Renal Dialysis; Renal Elimination; Renal Insufficiency, Chronic; Retrospective Studies; Staphylococcal Infections; Staphylococcus aureus | 2016 |
Trends in paediatric and adult bloodstream infections at a Ghanaian referral hospital: a retrospective study.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacteremia; Blood Culture; Cephalosporins; Child; Child, Preschool; Cloxacillin; Drug Resistance, Bacterial; Female; Ghana; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Hospitals, Teaching; Humans; Infant; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Thienamycins | 2016 |
Analysis of the third- and fourth-generation cephalosporin use for the treatment of infections caused by Gram-negative bacteria in hospital settings.
Topics: Anti-Bacterial Agents; Cephalosporins; Cross Infection; Cross-Sectional Studies; Drug Resistance, Microbial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Infection Control; Microbial Sensitivity Tests; Serbia | 2016 |
First case of pneumonia caused by Cupriavidus pauculus in an infant in the Gulf Cooperation Council.
Topics: Anti-Bacterial Agents; Cefepime; Cephalosporins; Cupriavidus; Gram-Negative Bacterial Infections; Humans; Infant; Kidney Failure, Chronic; Male; Microbial Sensitivity Tests; Pneumonia, Bacterial; Saudi Arabia | 2017 |
In vivo pharmacodynamics of ceftobiprole against multiple bacterial pathogens in murine thigh and lung infection models.
Topics: Animals; Anti-Bacterial Agents; Bacterial Infections; Cephalosporin Resistance; Cephalosporins; Disease Models, Animal; Dose-Response Relationship, Drug; Enterobacteriaceae Infections; Extremities; Female; Gram-Negative Bacterial Infections; Lung Diseases; Methicillin Resistance; Mice; Mice, Inbred ICR; Neutropenia; Penicillin Resistance; Pneumococcal Infections; Staphylococcal Infections; Staphylococcus aureus | 2008 |
Trends in Stenotrophomonas maltophilia bloodstream infection in relation to usage density of cephalosporins and carbapenems during 7 years.
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactams; Brazil; Carbapenems; Cephalosporins; Gram-Negative Bacterial Infections; Hospitals, University; Humans; Incidence; Stenotrophomonas maltophilia | 2008 |
Efficacy and safety of cefepime.
Topics: Anti-Bacterial Agents; Cefepime; Cephalosporins; Clinical Trials as Topic; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans | 2009 |
Failure of cefepime therapy in neutropenic patients with extended-spectrum beta-lactamase-producing Gram-negative bacteraemia.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Cefepime; Cephalosporins; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Male; Middle Aged; Neutropenia; Treatment Failure; Young Adult | 2009 |
[Intravitreal injection of antibiotics in endophthalmitis].
Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents; Blood-Retinal Barrier; Cephalosporins; Combined Modality Therapy; Drug Therapy, Combination; Endophthalmitis; Fluoroquinolones; Glycopeptides; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Half-Life; Humans; Injections; Retinal Detachment; Vancomycin; Vitrectomy; Vitreous Body | 2008 |
In vitro susceptibility pattern of cephalosporin-resistant Gram-negative bacteria.
Topics: Anti-Bacterial Agents; Cephalosporins; Colistin; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacterial Infections; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Thailand | 2008 |
Multiple drug-resistant Alcaligenes xylosoxidans keratitis in a sanitation worker.
Topics: Achromobacter denitrificans; Administration, Topical; Adult; Aminoglycosides; Anti-Bacterial Agents; Cephalosporins; Contact Lens Solutions; Contact Lenses; Drug Resistance, Multiple, Bacterial; Equipment Contamination; Eye Infections, Bacterial; Fluoroquinolones; Gram-Negative Bacterial Infections; Humans; Keratitis; Male; Microbial Sensitivity Tests; Occupational Diseases; Polymyxins; Sanitation; Toilet Facilities; Treatment Outcome; Trimethoprim | 2009 |
[Leech-borne infection on a TRAM flap: a case report].
Topics: Aeromonas hydrophila; Cephalosporins; Ciprofloxacin; Female; Gram-Negative Bacterial Infections; Humans; Leeching; Mammaplasty; Middle Aged; Rectus Abdominis; Surgical Flaps | 2010 |
The in-vivo antibacterial activity of ceftazidime (Gr 20263)--a comparison with other new beta-lactam antibiotics and gentamicin.
Topics: Agar; Animals; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Ceftazidime; Cephalosporins; Colony Count, Microbial; Female; Gentamicins; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Mice; Microbial Sensitivity Tests | 1981 |
Microbiological analysis of epidermal growth factor receptor inhibitor therapy-associated paronychia.
Topics: Anti-Bacterial Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Cephalosporins; Cetuximab; Ciprofloxacin; ErbB Receptors; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Levofloxacin; Ofloxacin; Paronychia; Retrospective Studies; Skin | 2010 |
Empiric combination antibiotic therapy is associated with improved outcome against sepsis due to Gram-negative bacteria: a retrospective analysis.
Topics: Acinetobacter Infections; Adult; Aged; Aminoglycosides; Anti-Bacterial Agents; Carbapenems; Cefepime; Cephalosporins; Cohort Studies; Drug Therapy, Combination; Escherichia coli Infections; Female; Fluoroquinolones; Gram-Negative Bacterial Infections; Hospital Mortality; Humans; Logistic Models; Male; Middle Aged; Multivariate Analysis; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Sepsis; Shock, Septic | 2010 |
Characterization of CSP-1, a novel extended-spectrum beta-lactamase produced by a clinical isolate of Capnocytophaga sputigena.
Topics: Amino Acid Sequence; Amoxicillin; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Capnocytophaga; Cephalosporins; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Sepsis | 2010 |
Ceftaroline for complicated skin and skin-structure infections.
Topics: Animals; Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Clinical Trials as Topic; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Methicillin-Resistant Staphylococcus aureus; Skin Diseases, Bacterial; Staphylococcal Infections | 2010 |
Cefepime-resistant Gram-negative bacteremia in febrile neutropenic patients with hematological malignancies.
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Cefepime; Cephalosporin Resistance; Cephalosporins; Escherichia coli; Escherichia coli Infections; Fever; Genes, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Hematologic Neoplasms; Humans; Klebsiella Infections; Klebsiella pneumoniae; Neutropenia; Pseudomonas aeruginosa; Pseudomonas Infections | 2010 |
Antibiotic susceptibility of respiratory pathogens recently isolated in Italy: focus on cefditoren.
Topics: Anti-Bacterial Agents; Cephalosporins; Community-Acquired Infections; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Italy; Microbial Sensitivity Tests; Respiratory Tract Infections | 2010 |
Asymptomatic catheter related Rhizobium radiobacter infection in a haploidentical hemapoetic stem cell recipient.
Topics: Agrobacterium tumefaciens; Amikacin; Anti-Bacterial Agents; Blood; Catheter-Related Infections; Catheterization, Central Venous; Catheters; Cefepime; Cephalosporins; Cross Infection; Female; Gram-Negative Bacterial Infections; Humans; Immunocompromised Host; Infant; Severe Combined Immunodeficiency; Stem Cell Transplantation | 2010 |
[Achromobacter xylosoxidans colonisation in bronchiectasis].
Topics: Achromobacter denitrificans; Animals; Anti-Bacterial Agents; Bacterial Typing Techniques; Bronchiectasis; Cattle; Cephalosporins; Culture Media; Disease Susceptibility; Disk Diffusion Antimicrobial Tests; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacterial Infections; Humans; Reproducibility of Results; Serum; Species Specificity | 2010 |
Restriction of cephalosporins and control of extended spectrum beta-lactamase producing gram negative bacteria in a neonatal intensive care unit.
Topics: Anti-Bacterial Agents; beta-Lactamases; Cephalosporin Resistance; Cephalosporins; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Infant, Newborn; Intensive Care Units, Neonatal; Male | 2010 |
Comparative activity of ceftobiprole against Gram-positive and Gram-negative isolates from Europe and the Middle East: the CLASS study.
Topics: Anti-Bacterial Agents; Cephalosporins; Drug Resistance, Multiple, Bacterial; Europe; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Middle East | 2011 |
Steady-state pharmacokinetics and pharmacodynamics of cefepime administered by prolonged infusion in hospitalised patients.
Topics: Adult; Aged; Anti-Bacterial Agents; Cefepime; Cephalosporins; Female; Gram-Negative Bacterial Infections; Hospitals; Humans; Infusions, Intravenous; Male; Microbial Sensitivity Tests; Middle Aged; Models, Statistical; Monte Carlo Method; Plasma; Time Factors | 2011 |
Epidemiology of culture isolates from peritoneal dialysis peritonitis patients in southern India using an automated blood culture system to culture peritoneal dialysate.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bacteriological Techniques; Candida; Candidiasis; Cephalosporins; Child; Dialysis Solutions; Drug Resistance, Bacterial; Female; Gram-Negative Aerobic Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; India; Kidney Failure, Chronic; Male; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Young Adult | 2011 |
In vitro activity of ceftobiprole against frequently encountered aerobic and facultative Gram-positive and Gram-negative bacterial pathogens: results of the CANWARD 2007-2009 study.
Topics: Anti-Bacterial Agents; Canada; Cephalosporins; Drug Resistance, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests | 2011 |
Cefepime effectiveness in Gram-negative bloodstream infections.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; Cefepime; Cephalosporins; Cohort Studies; Female; Gram-Negative Bacterial Infections; Humans; Male; Middle Aged; Retrospective Studies; Treatment Outcome; United States | 2011 |
Comamonas testosteroni infection in Taiwan: Reported two cases and literature review.
Topics: Aged; Alcoholism; Anti-Bacterial Agents; Bacteremia; Carcinoma, Hepatocellular; Cellulitis; Cephalosporins; Ciprofloxacin; Comamonas testosteroni; Gram-Negative Bacterial Infections; Hepatitis B, Chronic; Humans; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Taiwan; Treatment Outcome | 2011 |
Extended-spectrum beta-lactamase-mediated resistance among bacterial isolates recovered from ocular infections.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Cefotaxime; Cefpodoxime; Ceftazidime; Ceftizoxime; Ceftriaxone; Cephalosporin Resistance; Cephalosporins; Drug Resistance, Multiple, Bacterial; Eye Infections, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Prospective Studies | 2012 |
Recurrent intravascular-catheter-related bacteremia caused by Delftia acidovorans in a hemodialysis patient.
Topics: Anti-Bacterial Agents; Bacteremia; Catheter-Related Infections; Catheterization, Central Venous; Cephalosporins; Child; Delftia acidovorans; Female; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Renal Dialysis | 2011 |
First description of an RND-type multidrug efflux pump in Achromobacter xylosoxidans, AxyABM.
Topics: Achromobacter denitrificans; Aztreonam; Bacterial Outer Membrane Proteins; Cephalosporins; Chloramphenicol; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Multidrug Resistance-Associated Proteins; Nalidixic Acid | 2011 |
[Actual aspects of sepsis].
Topics: Acetamides; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Cefepime; Cephalosporins; Drug Resistance, Microbial; Enterobacteriaceae; Female; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Hospitals; Humans; Linezolid; Male; Microbial Sensitivity Tests; Middle Aged; Oxazolidinones; Retrospective Studies; Russia; Sepsis; Vancomycin | 2011 |
Evaluation of ceftobiprole activity against a variety of gram-negative pathogens, including Escherichia coli, Haemophilus influenzae (β-lactamase positive and β-lactamase negative), and Klebsiella pneumoniae, in a rabbit meningitis model.
Topics: Animals; Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Disease Models, Animal; Escherichia coli; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Haemophilus influenzae; Klebsiella pneumoniae; Meningitis, Bacterial; Microbial Sensitivity Tests; Rabbits; Treatment Outcome | 2012 |
Cefepime dosing in the morbidly obese patient population.
Topics: Anti-Bacterial Agents; Cefepime; Cephalosporins; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Female; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Male; Microbial Sensitivity Tests; Surgical Wound Infection; Treatment Outcome | 2012 |
Genetic and biochemical characterization of a novel metallo-β-lactamase, TMB-1, from an Achromobacter xylosoxidans strain isolated in Tripoli, Libya.
Topics: Achromobacter denitrificans; Amino Acid Sequence; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cephalosporins; Chromosomes, Bacterial; DNA, Bacterial; Gram-Negative Bacterial Infections; Humans; Integrons; Kinetics; Libya; Microbial Sensitivity Tests; Molecular Sequence Data; Pseudomonas aeruginosa; Sequence Alignment; Sequence Homology, Amino Acid | 2012 |
Cefepime for Gram-negative bacteremia in long-term hemodialysis: a single-center experience.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; Cefepime; Cephalosporins; Chronic Disease; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Gram-Negative Bacterial Infections; Humans; Kidney Diseases; Male; Middle Aged; Renal Dialysis; Retrospective Studies; Treatment Outcome | 2012 |
Activity of ceftaroline-avibactam tested against Gram-negative organism populations, including strains expressing one or more β-lactamases and methicillin-resistant Staphylococcus aureus carrying various staphylococcal cassette chromosome mec types.
Topics: Acinetobacter; Anti-Bacterial Agents; Azabicyclo Compounds; beta-Lactamase Inhibitors; beta-Lactamases; Ceftaroline; Cephalosporins; Chromosomes, Bacterial; Drug Combinations; Gram-Negative Bacterial Infections; Humans; Isoenzymes; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Plasmids; Pseudomonas aeruginosa; Staphylococcal Infections | 2012 |
Empiric antibiotics pending bronchoalveolar lavage data in patients without pneumonia significantly alters the flora, but not the resistance profile, if a subsequent pneumonia develops.
Topics: Acetamides; Anti-Bacterial Agents; Bronchoalveolar Lavage; Bronchoalveolar Lavage Fluid; Cefepime; Cephalosporins; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Linezolid; Male; Microbial Sensitivity Tests; Middle Aged; Oxazolidinones; Penicillanic Acid; Piperacillin; Pneumonia, Ventilator-Associated; Retrospective Studies; Tazobactam; Treatment Outcome; Vancomycin; Wounds and Injuries | 2013 |
Cutaneous abscess leading to sepsis by Aeromonas hydrophila.
Topics: Abscess; Aeromonas hydrophila; Cefepime; Cephalosporins; Ciprofloxacin; Fever; Gram-Negative Bacterial Infections; Humans; Male; Microbial Sensitivity Tests; Sepsis; Skin Diseases, Bacterial; Young Adult | 2013 |
[Current data and trends about the resistance of Gram-negative pathogens to beta-lactams].
Topics: beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Cephalosporins; Cross-Sectional Studies; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Europe; Germany; Gram-Negative Bacterial Infections; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Population Surveillance; Serotyping | 2012 |
[Enhancing efficacy of the primary antibacterial therapy for intraabdominal infections].
Topics: Adult; Aged; Anti-Bacterial Agents; Cephalosporins; Digestive System Surgical Procedures; Drug Therapy, Combination; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Intraabdominal Infections; Male; Middle Aged; Nitroimidazoles; Peritoneal Cavity; Ukraine | 2012 |
Pharmacodynamics of cefepime in patients with Gram-negative infections.
Topics: Anti-Bacterial Agents; Cefepime; Cephalosporins; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Hospitals, University; Hospitals, Urban; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Prospective Studies; Regression Analysis; Treatment Outcome; United States | 2002 |
Cefepime use in a pediatric intensive care unit reduces colonization with resistant bacilli.
Topics: Anti-Bacterial Agents; Cefepime; Cephalosporins; Child; Child, Preschool; Colony Count, Microbial; Cross Infection; Drug Resistance, Microbial; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Intensive Care Units, Pediatric; Male; Microbial Sensitivity Tests; Sensitivity and Specificity | 2003 |
Microbiology of choledochal bile in patients with choledocholithiasis admitted to a tertiary hospital.
Topics: Adult; Aged; Aged, 80 and over; Ampicillin; Anti-Bacterial Agents; Brazil; Cephalosporins; Cholangiopancreatography, Endoscopic Retrograde; Common Bile Duct; Disease Susceptibility; Female; Gallstones; Gentamicins; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Imipenem; Male; Microbial Sensitivity Tests; Middle Aged; Patient Admission; Penicillins; Treatment Outcome | 2003 |
[Bacterial resistance to antibiotics in gram-negative rods isolated from intensive care units. Comparative analysis between two periods (1998 and 2001)].
Topics: Acinetobacter; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Agents; Argentina; Cephalosporins; Child; Ciprofloxacin; Drug Resistance, Microbial; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; Infant, Newborn; Intensive Care Units; Klebsiella pneumoniae; Male; Middle Aged; Prospective Studies | 2003 |
Restriction of third-generation cephalosporin use decreases infection-related mortality.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; APACHE; Cephalosporin Resistance; Cephalosporins; Cross Infection; Female; Gram-Negative Bacterial Infections; Humans; Logistic Models; Male; Middle Aged; Prospective Studies; Risk Factors; Survival Rate | 2003 |
In vitro and in vivo laboratory evaluation of cephalothin, a new broad spectrum antibiotic.
Topics: Animals; Anti-Bacterial Agents; Cephalosporins; Cephalothin; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; In Vitro Techniques; Mice | 1962 |
In vitro susceptibilities of gram-negative bacteria isolated from hospitalized patients in four European countries, Canada, and the United States in 2000-2001 to expanded-spectrum cephalosporins and comparator antimicrobials: implications for therapy.
Topics: Anti-Bacterial Agents; Canada; Cephalosporins; Cross Infection; Europe; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Retrospective Studies; United States | 2003 |
[Post-marketing surveillance of antibacterial activities of cefozopran against various clinical isolates--II. Gram-negative bacteria].
Topics: Carbapenems; Cefozopran; Cephalosporins; Drug Resistance, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Monobactams; Penicillins; Product Surveillance, Postmarketing; Time Factors | 2003 |
Antibiotic susceptibility of bacteria most commonly isolated from bone related infections: the role of cephalosporins in antimicrobial therapy.
Topics: Bacterial Infections; Cephalosporins; Drug Resistance, Bacterial; Escherichia coli Infections; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Klebsiella Infections; Klebsiella pneumoniae; Osteomyelitis; Staphylococcal Infections; Streptococcal Infections; United States | 2004 |
Underdiagnosis of urinary tract infection caused by Methylobacterium species with current standard processing of urine culture and its clinical implications.
Topics: Adult; Aminoglycosides; Anti-Bacterial Agents; Bacteremia; Cephalosporins; Child, Preschool; Colony Count, Microbial; Culture Media; Escherichia coli; Female; Gram-Negative Bacterial Infections; Humans; Immunocompetence; Methylobacterium; Microbial Sensitivity Tests; Middle Aged; Urinary Tract Infections; Urine | 2004 |
In vitro activity of cefepime and cefpirome compared to other third-generation cephem antibiotics against gram-negative nosocomial pathogens.
Topics: Cefepime; Cefpirome; Cephalosporins; Cross Infection; Drug Resistance, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Microbial Sensitivity Tests | 2004 |
Clinical and laboratory features of spontaneous bacterial peritonitis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cephalosporins; Female; Gram-Negative Bacterial Infections; Humans; Liver Cirrhosis; Male; Middle Aged; Peritonitis; Retrospective Studies | 2004 |
Cefdinir: an oral alternative to parenteral cephems.
Topics: Administration, Oral; Anti-Bacterial Agents; Cefdinir; Cephalosporins; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Microbial Sensitivity Tests | 2005 |
Continuous infusion beta-lactams for intensive care unit pulmonary infections.
Topics: Anti-Bacterial Agents; Aztreonam; beta-Lactams; Cefepime; Ceftazidime; Cephalosporins; Computer Simulation; Drug Combinations; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Infusions, Intravenous; Intensive Care Units; Microbial Sensitivity Tests; Monte Carlo Method; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pneumonia, Bacterial; United States | 2005 |
Gram-negative bacterial resistance to cephalosporins in community-acquired infections in Turkey.
Topics: Anti-Bacterial Agents; Cephalosporin Resistance; Cephalosporins; Community-Acquired Infections; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Turkey | 2005 |
Intermittent administration of betalactam-antibiotics for treatment of severe infection in hemodialysis patients.
Topics: Amoxicillin; Anti-Bacterial Agents; beta-Lactams; C-Reactive Protein; Cefepime; Ceftazidime; Cephalosporins; Female; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Piperacillin; Renal Dialysis; Treatment Outcome | 2005 |
Potency and spectrum trends for cefepime tested against 65746 clinical bacterial isolates collected in North American medical centers: results from the SENTRY Antimicrobial Surveillance Program (1998-2003).
Topics: Anti-Bacterial Agents; Cefepime; Cephalosporins; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; North America | 2005 |
Interleukin-12 and -18 levels in peritoneal dialysate effluent correlate with the outcome of peritonitis in patients undergoing peritoneal dialysis: implications for the Type I/Type II T-cell immune response.
Topics: Adult; Ascitic Fluid; Cephalosporins; DNA-Binding Proteins; Drug Therapy, Combination; Female; GATA3 Transcription Factor; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Interferon-gamma; Interleukin-12; Interleukin-18; Kidney Failure, Chronic; Leukocyte Count; Male; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; RNA, Messenger; T-Box Domain Proteins; T-Lymphocyte Subsets; Teicoplanin; Th1 Cells; Th2 Cells; Trans-Activators; Transcription Factors; Treatment Outcome | 2005 |
Relationships between antimicrobial use and antimicrobial resistance in Gram-negative bacteria causing nosocomial infections from 1991-2003 at a university hospital in Taiwan.
Topics: Aminoglycosides; Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Carbapenems; Cephalosporins; Cross Infection; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Hospitals, University; Humans; Incidence; Length of Stay; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Taiwan | 2005 |
Combined cephalosporin aminoglycoside therapy in gram-negative sepsis. The choice of cephalosporin.
Topics: Adult; Aged; Aminoglycosides; Anti-Bacterial Agents; Bacteria, Anaerobic; Ceftazidime; Cephalosporins; Drug Therapy, Combination; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Male; Middle Aged; Sepsis | 1989 |
Antimicrobial activity and spectrum of cefovecin, a new extended- spectrum cephalosporin, against pathogens collected from dogs and cats in Europe and North America.
Topics: Animals; Anti-Bacterial Agents; Cat Diseases; Cats; Cephalosporins; Dog Diseases; Dogs; Drug Resistance, Bacterial; Europe; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Microbial Sensitivity Tests; North America | 2006 |
The association of third-generation cephalosporin use and invasive candidiasis in extremely low birth-weight infants.
Topics: Blood; Candidiasis; Carbapenems; Catheterization, Central Venous; Central Nervous System Fungal Infections; Cephalosporins; Cerebrospinal Fluid; Comorbidity; Cross Infection; Enterocolitis, Necrotizing; Fungemia; Gram-Negative Bacterial Infections; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Infant, Very Low Birth Weight; Prospective Studies; Registries; Risk Factors; Superinfection | 2006 |
Comparisons of parenteral broad-spectrum cephalosporins tested against bacterial isolates from pediatric patients: report from the SENTRY Antimicrobial Surveillance Program (1998-2004).
Topics: Adolescent; Anti-Bacterial Agents; Cefepime; Ceftriaxone; Cephalosporins; Child; Child, Preschool; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Infant; Infant, Newborn; Microbial Sensitivity Tests; North America; Sentinel Surveillance | 2007 |
Pharmacokinetic-pharmacodynamic rationale for cefepime dosing regimens in intensive care units.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Anti-Bacterial Agents; Cefepime; Cephalosporins; Drug Administration Schedule; Escherichia coli; Escherichia coli Infections; Female; Gram-Negative Bacterial Infections; Humans; Intensive Care Units; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Models, Biological; Pseudomonas aeruginosa; Pseudomonas Infections | 2006 |
Treatment of bone and joint infections caused by Gram-negative bacilli with a cefepime-fluoroquinolone combination.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bone Diseases, Infectious; Cefepime; Cephalosporins; Ciprofloxacin; Drug Therapy, Combination; Female; Gram-Negative Bacterial Infections; Humans; Joint Diseases; Male; Middle Aged; Ofloxacin; Retrospective Studies | 2006 |
Urinary bactericidal activity of oral antibiotics against common urinary tract pathogens in an ex vivo model.
Topics: Acetamides; Administration, Oral; Adult; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Anti-Infective Agents, Urinary; beta-Lactamases; Biomarkers; Cefadroxil; Ceftibuten; Cefuroxime; Cephalexin; Cephalosporins; Ciprofloxacin; Disk Diffusion Antimicrobial Tests; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Linezolid; Middle Aged; Norfloxacin; Oxazolidinones; Time Factors; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections | 2006 |
Carbapenem-resistant Acinetobacter baumannii: an emerging threat for patients with post-neurosurgical meningitis.
Topics: Acinetobacter baumannii; Adolescent; Adult; Aged; Amikacin; Anti-Bacterial Agents; Carbapenems; Cefepime; Cefoperazone; Cephalosporins; Ciprofloxacin; Drug Resistance, Bacterial; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; Male; Meningitis, Bacterial; Meropenem; Microbial Sensitivity Tests; Middle Aged; Neurosurgical Procedures; Postoperative Complications; Thienamycins; Turkey | 2007 |
The impact of an antibiotic cycling program on empirical therapy for gram-negative infections.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Carbapenems; Cephalosporins; Cross Infection; Drug Administration Schedule; Drug Resistance, Bacterial; Drug Resistance, Multiple; Empiricism; Female; Fluoroquinolones; Gram-Negative Bacterial Infections; Hospitals, Teaching; Humans; Intensive Care Units; Male; Middle Aged; Missouri; Penicillins; Pneumonia, Bacterial; Prospective Studies; Survival Rate; Urinary Tract Infections; Ventilators, Mechanical | 2006 |
Population pharmacokinetics and pharmacodynamics of cefpirome in critically ill patients against Gram-negative bacteria.
Topics: Adult; Aged; Anti-Bacterial Agents; Cefpirome; Cephalosporins; Creatinine; Critical Illness; Dose-Response Relationship, Drug; Female; Gram-Negative Bacterial Infections; Humans; Infusions, Intravenous; Intensive Care Units; Male; Metabolic Clearance Rate; Middle Aged; Models, Biological; Monte Carlo Method | 2007 |
Epidemiology of bacteremia and factors associated with multi-drug-resistant gram-negative bacteremia in hematopoietic stem cell transplant recipients.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacteremia; Brazil; Carbapenems; Cephalosporins; Child; Child, Preschool; Drug Resistance, Multiple; Female; Gram-Negative Bacterial Infections; Hematopoietic Stem Cell Transplantation; Humans; Incidence; Infant; Male; Middle Aged; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Predictive Value of Tests; Prospective Studies; Risk Factors | 2007 |
Predictive model of antimicrobial-resistant gram-negative bacteremia at the ED.
Topics: Adult; Aged; Analysis of Variance; Anti-Infective Agents; Bacteremia; Cephalosporins; Decision Support Techniques; Drug Resistance, Microbial; Emergency Service, Hospital; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Male; Middle Aged; Prospective Studies; Risk Factors; ROC Curve | 2007 |
Cefepime restriction improves gram-negative overall resistance patterns in neonatal intensive care unit.
Topics: Anti-Bacterial Agents; Cefepime; Cephalosporins; Cohort Studies; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacterial Infections; Humans; Infant, Newborn; Infant, Premature; Intensive Care Units, Neonatal; Meropenem; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Thienamycins; Time Factors | 2007 |
Rapid detection of extended-spectrum beta-lactamase-producing Gram-negative bacilli in blood cultures.
Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; Blood; Cephalosporins; Clavulanic Acid; Color; Culture Media; Enzyme Inhibitors; False Positive Reactions; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Hydrolysis | 2007 |
One year trends in the gram-negative bacterial antibiotic susceptibility patterns in a medical intensive care unit in South India.
Topics: Carbapenems; Cefotaxime; Ceftazidime; Cephalosporins; Drug Resistance, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; India; Intensive Care Units; Microbial Sensitivity Tests | 2007 |
Comparison of clinical cure rates in adults with ventilator-associated pneumonia treated with intravenous ceftazidime administered by continuous or intermittent infusion: a retrospective, nonrandomized, open-label, historical chart review.
Topics: Aged; APACHE; Ceftazidime; Cephalosporins; Female; Gram-Negative Bacterial Infections; Humans; Infusions, Intravenous; Injections, Intravenous; Male; Middle Aged; Pneumonia, Ventilator-Associated; Regression Analysis; Retrospective Studies; Treatment Outcome | 2007 |
Gram-negative organisms predominate in Hickman line-related infections in non-neutropenic patients with hematological malignancies.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacteremia; Catheterization, Central Venous; Catheters, Indwelling; Cefepime; Cephalosporins; Cohort Studies; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Hematologic Neoplasms; Humans; Incidence; Male; Middle Aged; Neutropenia; Retrospective Studies; Vancomycin; Victoria | 2008 |
In-vitro and in-vivo activity of DWC-751, a new cephalosporin.
Topics: Animals; Anti-Bacterial Agents; Cefotaxime; Ceftazidime; Cephalosporins; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Male; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests | 1994 |
Aeromonas hydrophila epiglottitis: a case report.
Topics: Aeromonas hydrophila; beta-Thalassemia; Cephalosporins; Child; Epiglottitis; Female; Gram-Negative Bacterial Infections; Humans | 1993 |
Aeromonas species in septicemia: laboratory characteristics and clinical observations.
Topics: Adolescent; Adult; Aeromonas; Aeromonas hydrophila; Aged; Aged, 80 and over; Animals; Carbenicillin; Cephalosporins; Child; Child, Preschool; Drug Resistance, Microbial; Female; Gram-Negative Bacterial Infections; Humans; Infant; Infant, Newborn; Male; Mice; Middle Aged; Sepsis; Serologic Tests; Virulence | 1994 |
Antimicrobial activity of cefepime tested against Bush group I beta-lactamase-producing strains resistant to ceftazidime. A multilaboratory national and international clinical isolate study.
Topics: beta-Lactamases; Cefepime; Ceftazidime; Cephalosporin Resistance; Cephalosporins; Ciprofloxacin; Cross Infection; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; International Cooperation; Microbial Sensitivity Tests | 1994 |
Optimal times above MICs of ceftibuten and cefaclor in experimental intra-abdominal infections.
Topics: Abdomen; Animals; Bacterial Infections; Cefaclor; Ceftibuten; Cephalosporins; Female; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Half-Life; Mice; Time Factors | 1994 |
Gram-negative bacillary meningitis in adults: a recent six-year experience.
Topics: Cephalosporins; Female; Gram-Negative Bacterial Infections; Humans; Male; Meningitis, Bacterial; Middle Aged; Prognosis | 1993 |
[Diffusion of cefpirome in ascitic fluid].
Topics: Adult; Ascitic Fluid; Cefpirome; Cephalosporins; Diffusion; Female; Gram-Negative Bacterial Infections; Humans; Injections, Intravenous; Liver Cirrhosis; Male; Middle Aged | 1993 |
In-vitro activities of cefepime against Enterobacter cloacae, Serratia marcescens, Pseudomonas aeruginosa and other aerobic gram-negative bacilli.
Topics: Aminoglycosides; Anti-Bacterial Agents; Aztreonam; Cefepime; Cephalosporins; Doxycycline; Enterobacter cloacae; Gram-Negative Aerobic Bacteria; Gram-Negative Bacterial Infections; Humans; Korea; Penicillins; Pseudomonas aeruginosa; Serratia marcescens | 1993 |
Intestinal flora of the medicinal leech Hirudinaria manillensis.
Topics: Aeromonas; Animals; Cephalosporins; Gram-Negative Bacterial Infections; Humans; Intestines; Leeches | 1994 |
Activity of imipenem, third-generation cephalosporins, aztreonam and ciprofloxacin against multi-resistant gram-negative bacilli isolated from Chilean hospitals.
Topics: Anti-Bacterial Agents; Aztreonam; Cephalosporins; Chile; Ciprofloxacin; Cross Infection; Drug Resistance, Microbial; Drug Synergism; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; Indicators and Reagents; Microbial Sensitivity Tests | 1993 |
Pharmacokinetics of antibiotics against gram-negative infections in continuous ambulatory peritoneal dialysis patients.
Topics: Aminoglycosides; Anti-Bacterial Agents; Cephalosporins; Gram-Negative Bacterial Infections; Humans; Peritoneal Dialysis, Continuous Ambulatory | 1993 |
Monotherapy of gram-negative nosocomial pneumonia.
Topics: Adult; Cephalosporins; Cross Infection; Gram-Negative Bacterial Infections; Humans; Male; Pneumonia; Risk Factors; Wounds and Injuries | 1993 |
Capnocytophaga endophthalmitis.
Topics: Adolescent; Capnocytophaga; Cephalosporins; Endophthalmitis; Eye Enucleation; Eye Infections, Bacterial; Gram-Negative Bacterial Infections; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Visual Acuity | 1993 |
In vitro susceptibilities of tropical strains of Aeromonas species from Queensland, Australia, to 22 antimicrobial agents.
Topics: 4-Quinolones; Aeromonas; Aminoglycosides; Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Gram-Negative Bacterial Infections; Humans; Penicillins; Queensland | 1993 |
Capnocytophaga ochracea chronic blepharoconjunctivitis.
Topics: Aged; Blepharitis; Capnocytophaga; Cefazolin; Cephalosporins; Chronic Disease; Conjunctiva; Conjunctivitis; Eye Infections, Bacterial; Female; Gingiva; Gram-Negative Bacterial Infections; Humans; Ophthalmic Solutions | 1995 |
Aeromonas hydrophila lung abscess in a previously healthy man.
Topics: Aeromonas; Bronchoalveolar Lavage Fluid; Cefuroxime; Cephalosporins; Gram-Negative Bacterial Infections; Humans; Lung; Lung Abscess; Male; Middle Aged; Sputum | 1995 |
[Bacteremic peritonitis caused by Aeromonas hydrophila in a woman with cirrhosis].
Topics: Aeromonas hydrophila; Bacteremia; Cefotaxime; Cephalosporins; Chronic Disease; Female; Gram-Negative Bacterial Infections; Humans; Liver Cirrhosis; Middle Aged; Peritonitis | 1996 |
[Bacteremia caused by Capnocytophaga sp: presentation of 2 cases, one with endocarditis. Review of the literature].
Topics: Adult; Aged; Amikacin; Anti-Bacterial Agents; Bacteremia; Capnocytophaga; Cefotaxime; Ceftazidime; Cephalosporins; Endocarditis, Bacterial; Female; Gram-Negative Bacterial Infections; Humans; Male | 1996 |
[A clinical evaluation of the efficacy of using Zanocin (ofloxacin) in surgery].
Topics: Adult; Anti-Infective Agents; Biliary Fistula; Cefazolin; Cephalosporins; Cholangitis; Drug Evaluation; Drug Therapy, Combination; Gram-Negative Bacterial Infections; Humans; Middle Aged; Ofloxacin | 1995 |
Development of Aeromonas hydrophila bacteremia in a patient recovering from cholera.
Topics: Adult; Aeromonas; Bacteremia; Ceftriaxone; Cephalosporins; Cholera; Cross Infection; Drug Resistance, Microbial; Female; Gram-Negative Bacterial Infections; Humans | 1996 |
Prevention of infection in children with acute leukaemia. No major difference between total and selective bowel decontamination.
Topics: Adolescent; Amphotericin B; Anti-Bacterial Agents; Bacteremia; Bacterial Infections; Carboxymethylcellulose Sodium; Cephaloridine; Cephalosporins; Child; Child, Preschool; Colistin; Drug Therapy, Combination; Food Handling; Gram-Negative Bacterial Infections; Humans; Infant; Intestines; Leukemia, Myeloid, Acute; Neomycin; Neutropenia; Pneumonia, Pneumocystis; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Retrospective Studies; Sterilization; Trimethoprim, Sulfamethoxazole Drug Combination | 1996 |
Corneal ulcers in two institutions in Singapore: analysis of causative factors, organisms and antibiotic resistance.
Topics: Adult; Anti-Bacterial Agents; Bacterial Infections; Cephalosporins; Chloramphenicol Resistance; Contact Lenses; Corneal Ulcer; Drug Resistance, Microbial; Equipment Contamination; Eye Diseases; Eye Injuries; Female; Gentamicins; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Keratitis; Male; Middle Aged; Occupational Diseases; Proteus Infections; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Risk Factors; Singapore | 1995 |
In vitro and in vivo activities of LB10522, a new catecholic cephalosporin.
Topics: Animals; beta-Lactamases; Cephalosporins; Drug Stability; Enterobacteriaceae; Enzyme Induction; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Male; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests | 1996 |
Antimicrobial resistance rates among aerobic gram-negative bacilli recovered from patients in intensive care units: evaluation of a national postmarketing surveillance program.
Topics: Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Ceftazidime; Cephalosporins; Ciprofloxacin; Drug Resistance, Microbial; Enterobacter; Gram-Negative Aerobic Bacteria; Gram-Negative Bacterial Infections; Hospital Bed Capacity; Hospitals, Teaching; Humans; Imipenem; Intensive Care Units; Klebsiella pneumoniae; Lung; Microbial Sensitivity Tests; Product Surveillance, Postmarketing; Pseudomonas aeruginosa; Risk Factors; Thienamycins; Wounds and Injuries | 1996 |
[Morphological response of urinary bacteria to ceftibuten].
Topics: Ceftibuten; Cell Wall; Cephalosporins; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Microscopy, Electron; Microscopy, Phase-Contrast; Urinary Tract Infections | 1996 |
Agrobacterium radiobacter pneumonia in a patient with HIV infection.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; CD4 Lymphocyte Count; Ceftriaxone; Cephalosporins; Female; Gentamicins; Gram-Negative Bacterial Infections; HIV Infections; Humans; Microbial Sensitivity Tests; Netilmicin; Pneumonia, Bacterial; Rhizobium; Stavudine | 1996 |
[Antimicrobial activities of cefetamet against clinical isolates from urinary tract infection].
Topics: Ceftizoxime; Cephalosporins; Drug Resistance, Microbial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Prodrugs; Urinary Tract Infections | 1996 |
Flavobacterium indologenes keratitis.
Topics: Administration, Topical; Ceftazidime; Cephalosporins; Cornea; Corneal Ulcer; Eye Infections, Bacterial; Flavobacterium; Gram-Negative Bacterial Infections; Humans; Male; Middle Aged; Ophthalmic Solutions; Opportunistic Infections | 1997 |
Hydrolysis of imipenem, meropenem, ceftazidime, and cefepime by multiresistant nosocomial strains of Sphingobacterium multivorum.
Topics: Cefepime; Ceftazidime; Cephalosporins; Cross Infection; Drug Resistance, Microbial; Drug Resistance, Multiple; Flavobacterium; Gram-Negative Bacterial Infections; Humans; Hydrolysis; Imipenem; Meropenem; Microbial Sensitivity Tests; Thienamycins | 1997 |
Successful treatment of Stomatococcus mucilaginosus meningitis with intravenous vancomycin and intravenous ceftriaxone.
Topics: Anti-Bacterial Agents; Ceftriaxone; Cephalosporins; Child, Preschool; Gram-Negative Bacterial Infections; Humans; Infusions, Intravenous; Meningitis, Bacterial; Vancomycin | 1997 |
Tazobactam-piperacillin compared with sulbactam-ampicillin, clavulanic acid-ticarcillin, sulbactam-cefoperazone, and piperacillin for activity against beta-lactamase-producing bacteria isolated from patients with complicated urinary tract infections.
Topics: Ampicillin; beta-Lactamase Inhibitors; Cefoperazone; Cephalosporins; Clavulanic Acid; Clavulanic Acids; Colony Count, Microbial; Dose-Response Relationship, Drug; Drug Therapy, Combination; Enzyme Inhibitors; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Penicillins; Piperacillin; Retrospective Studies; Sulbactam; Tazobactam; Ticarcillin; Urinary Tract; Urinary Tract Infections | 1997 |
In vitro activity of cefoperazone-sulbactam: Singapore experience.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Cefoperazone; Cephalosporin Resistance; Cephalosporins; Drug Therapy, Combination; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Singapore; Sulbactam | 1996 |
Capnocytophaga canimorsus septicemia in an asplenic patient.
Topics: Aged; Animals; Bites and Stings; Capnocytophaga; Cats; Ceftizoxime; Cephalosporins; Diagnosis, Differential; Disease Vectors; Dogs; Female; Gram-Negative Bacterial Infections; Humans; Sepsis | 1997 |
Submandibular abscess caused by Eikenella corrodens.
Topics: Adult; Cefuroxime; Cephalosporins; Eikenella corrodens; Female; Gram-Negative Bacterial Infections; Humans; Neck; Retropharyngeal Abscess; Tooth Extraction | 1997 |
Molecular epidemiology of acquisition of ceftazidime-resistant gram-negative bacilli in a nonoutbreak setting.
Topics: Acinetobacter; Ceftazidime; Cephalosporin Resistance; Cephalosporins; Cohort Studies; Electrophoresis, Gel, Pulsed-Field; Enterobacteriaceae; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Intensive Care Units; Population Surveillance; Prospective Studies; Pseudomonas aeruginosa | 1997 |
Scheduled change of antibiotic classes: a strategy to decrease the incidence of ventilator-associated pneumonia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Bacteremia; Ceftazidime; Cephalosporin Resistance; Cephalosporins; Ciprofloxacin; Drug Administration Schedule; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Hospital Mortality; Humans; Incidence; Male; Middle Aged; Pneumonia, Bacterial; Prospective Studies; Respiration, Artificial | 1997 |
Susceptibilities of Chryseobacterium indologenes and Chryseobacterium meningosepticum to cefepime and cefpirome.
Topics: Cefepime; Cefpirome; Cephalosporins; Cross Infection; Drug Resistance, Microbial; Flavobacterium; Gram-Negative Bacterial Infections; Humans; In Vitro Techniques; Microbial Sensitivity Tests | 1997 |
The choice of antibacterial drugs.
Topics: Administration, Oral; Anti-Bacterial Agents; Cefotaxime; Ceftazidime; Cephalosporins; Community-Acquired Infections; Costs and Cost Analysis; Cross Infection; Drug Resistance, Microbial; Drug Resistance, Multiple; Enterococcus; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Humans; Macrolides; Meningitis, Bacterial; Meningitis, Meningococcal; Meningitis, Pneumococcal; Microbial Sensitivity Tests; Neutropenia; Pneumococcal Infections; Pneumonia, Bacterial; Systemic Inflammatory Response Syndrome; Urinary Tract Infections | 1998 |
Congenital endophthalmitis following maternal shellfish ingestion.
Topics: Animals; Bacteremia; Cefotaxime; Cephalosporins; Cyclopentolate; Endophthalmitis; Eye Infections, Bacterial; Female; Food Microbiology; Gram-Negative Bacterial Infections; Humans; Infant, Newborn; Male; Maternal-Fetal Exchange; Meningitis, Bacterial; Mydriatics; Ostreidae; Plesiomonas; Pregnancy; Pregnancy Complications, Infectious | 1998 |
Cefazolin in chronic hemodialysis patients: a safe, effective alternative to vancomycin.
Topics: Ambulatory Care; Anti-Bacterial Agents; Bacteremia; Cefazolin; Cephalosporins; Drug Therapy, Combination; Enterococcus; Gentamicins; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Metabolic Clearance Rate; Methicillin Resistance; Microbial Sensitivity Tests; Renal Dialysis; Staphylococcus; Vancomycin; Wound Infection | 1998 |
Inducible beta-lactam resistance in Aeromonas hydrophila: therapeutic challenge for antimicrobial therapy.
Topics: Aeromonas hydrophila; Bacteremia; Base Sequence; beta-Lactamases; Burns; Cephalosporin Resistance; Cephalosporins; Cross Infection; DNA Primers; DNA, Bacterial; Electrophoresis, Gel, Pulsed-Field; Female; Genotype; Gram-Negative Bacterial Infections; Humans; Middle Aged; Mutation; Polymerase Chain Reaction; Surgical Wound Infection | 1998 |
Sensitivity pattern and beta-lactamase production in clinical isolates of Aeromonas strains.
Topics: Aeromonas; Ampicillin Resistance; Anti-Bacterial Agents; beta-Lactamases; Cefotaxime; Cephalosporins; Chloramphenicol; Ciprofloxacin; Drug Resistance, Microbial; Gram-Negative Bacterial Infections; Humans; Imipenem; Microbial Sensitivity Tests; Pakistan; Thienamycins; Trimethoprim, Sulfamethoxazole Drug Combination | 1998 |
Activity of a broad-spectrum cephalosporin (Ro 48-8391) alone and in combination with two novel beta-lactamase inhibitors (Ro 48-5545 and Ro 48-8724).
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamase Inhibitors; Cephalosporins; Enzyme Inhibitors; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests | 1998 |
Utility of serial rectal swab cultures for detection of ceftazidime- and imipenem-resistant gram-negative bacilli from patients in the intensive care unit.
Topics: Adult; Aged; beta-Lactam Resistance; Ceftazidime; Cephalosporins; Cross Infection; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; Intensive Care Units; Microbial Sensitivity Tests; Middle Aged; Prospective Studies; Rectum; Thienamycins | 1998 |
Aeromonas species isolated from medicinal leeches.
Topics: Aeromonas; Animals; Anti-Bacterial Agents; Cefoperazone; Cephalosporins; Gram-Negative Bacterial Infections; Intestines; Leeches; Microbial Sensitivity Tests; Solutions; Tetracycline; Wound Infection | 1999 |
Determination of the antimicrobial activity of 29 clinically important compounds tested against fastidious HACEK group organisms.
Topics: Anti-Bacterial Agents; Carbapenems; Cephalosporins; Fluoroquinolones; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Penicillins | 1999 |
Ochrobactrum anthropi meningitis in a pre-term neonate.
Topics: Alcaligenes; Cefotaxime; Cephalosporins; Female; Gentamicins; Gram-Negative Bacterial Infections; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Meningitis, Bacterial; Respiratory Distress Syndrome, Newborn | 1999 |
Beta-lactamases and outer membrane investigations in beta-lactam-resistant Comamonas acidovorans strains.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; beta-Lactam Resistance; beta-Lactamases; Cell Membrane Permeability; Cephalosporins; Gram-Negative Aerobic Rods and Cocci; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests | 1999 |
Molecular epidemiology of ceftazidime-resistant gram-negative bacilli on inanimate surfaces and their role in cross-transmission during nonoutbreak periods.
Topics: Ceftazidime; Cephalosporins; Drug Resistance, Microbial; Environmental Microbiology; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Health Personnel; Humans | 1999 |
AS-924, a novel bifunctional prodrug of ceftizoxime.
Topics: Animals; Bacteria; Ceftizoxime; Cephalosporins; Dogs; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Male; Mice; Microbial Sensitivity Tests; Molecular Structure; Prodrugs; Rabbits; Rats; Rats, Wistar | 1999 |
Use of cefazolin for peritonitis treatment in peritoneal dialysis patients.
Topics: Cefazolin; Cephalosporins; Colony Count, Microbial; Drug Resistance, Microbial; Drug Resistance, Multiple; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Kidney Failure, Chronic; Microbial Sensitivity Tests; Peritoneal Dialysis, Continuous Ambulatory; Peritoneum; Peritonitis; Retrospective Studies; Treatment Outcome | 1999 |
Bacteremia with CDC group IV c-2 in an immunocompetent infant.
Topics: Bacteremia; Cefotaxime; Cephalosporins; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Immunocompetence; Infant | 1999 |
[The comparative activity of cefepime and other current antibiotics against microorganisms isolated from patients in pediatric intensive therapy units].
Topics: Anti-Bacterial Agents; Cefepime; Cephalosporins; Child; Cross Infection; Dose-Response Relationship, Drug; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Intensive Care Units, Pediatric; Microbial Sensitivity Tests | 1999 |
Comparison of effects of medium composition and atmospheric conditions on detection of Bilophila wadsworthia beta-lactamase by cefinase and cefinase plus methods.
Topics: Aerobiosis; Anaerobiosis; beta-Lactamases; Cephalosporins; Culture Media; Gram-Negative Anaerobic Bacteria; Gram-Negative Bacterial Infections; Humans; Indicators and Reagents; Microbial Sensitivity Tests; Penicillins | 2000 |
Modelling and forecasting antimicrobial resistance and its dynamic relationship to antimicrobial use: a time series analysis.
Topics: Anti-Bacterial Agents; Ceftazidime; Cephalosporins; Drug Resistance, Microbial; Drug Utilization; Forecasting; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; Models, Biological; Pseudomonas aeruginosa; Pseudomonas Infections; Thienamycins; Time Factors | 2000 |
Treatment of gram-negative bacterial meningitis in term neonates with third generation cephalosporins plus amikacin.
Topics: Amikacin; Anti-Bacterial Agents; Cefotaxime; Ceftazidime; Cephalosporin Resistance; Cephalosporins; Drug Therapy, Combination; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Greece; Humans; Infant, Newborn; Male; Meningitis, Bacterial; Morbidity; Retrospective Studies | 2000 |
An antibiotic policy to prevent emergence of resistant bacilli.
Topics: Amoxicillin; Cefotaxime; Cephalosporins; Cross-Sectional Studies; Drug Resistance, Microbial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Infant, Newborn; Intensive Care Units, Neonatal; Organizational Policy; Penicillins; Prospective Studies; Sepsis | 2000 |
Antimicrobial activity and in vitro susceptibility test development for cefditoren against Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus species.
Topics: Cefaclor; Cefixime; Cephalosporins; Gram-Negative Bacterial Infections; Haemophilus Infections; Haemophilus influenzae; Humans; Microbial Sensitivity Tests; Moraxella catarrhalis; Penicillins; Streptococcal Infections; Streptococcus | 2000 |
Clinical features and therapeutic implications of 104 episodes of monomicrobial Aeromonas bacteraemia.
Topics: Adolescent; Adult; Aeromonas; Aged; Aminoglycosides; Anti-Bacterial Agents; Bacteremia; Cefotaxime; Cephalosporin Resistance; Cephalosporins; Community-Acquired Infections; Cross Infection; Drug Therapy, Combination; Female; Gram-Negative Bacterial Infections; Humans; Lactams; Male; Middle Aged; Prognosis; Risk Factors | 2000 |
Antibiotic resistance and exposure to different generation cephalosporins.
Topics: Cephalosporins; Drug Resistance, Multiple; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Intensive Care Units | 2000 |
Use of 'locked-in' antibiotic to treat an unusual gram-negative hemodialysis catheter infection.
Topics: Adult; Catheters, Indwelling; Ceftazidime; Cephalosporins; Female; Gram-Negative Bacterial Infections; Humans; Injections, Intravenous; Kidney Failure, Chronic; Renal Dialysis; Stenotrophomonas maltophilia | 2000 |
[Spontaneous bacterial peritonitis caused by Alcaligenes xylosoxidans].
Topics: Adult; Alcaligenes; Ceftriaxone; Cephalosporins; Gram-Negative Bacterial Infections; Humans; Liver Diseases, Alcoholic; Male; Peritonitis; Time Factors | 2000 |
Prediction of gram-negative bacteremia in patients with cancer and febrile neutropenia by means of interleukin-8 levels in serum: targeting empirical monotherapy versus combination therapy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bacteremia; Cefepime; Cephalosporins; Drug Therapy, Combination; Fever; Gentamicins; Gram-Negative Bacterial Infections; Humans; Interleukin-8; Leukemia; Lymphoma; Male; Middle Aged; Netilmicin; Neutropenia; Predictive Value of Tests; Prospective Studies | 2001 |
Comparative activities of isepamicin, amikacin, cefepime, and ciprofloxacin alone or in combination with other antibiotics against Stenotrophomonas maltophilia.
Topics: Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Cefepime; Cephalosporins; Ciprofloxacin; Colony Count, Microbial; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Drug Synergism; Drug Therapy, Combination; Gentamicins; Gram-Negative Bacterial Infections; Microbial Sensitivity Tests; Stenotrophomonas maltophilia; Time Factors | 2001 |
In vitro and in vivo combinations of cefotaxime and minocycline against Aeromonas hydrophila.
Topics: Aeromonas hydrophila; Animals; Anti-Bacterial Agents; Cefotaxime; Cephalosporins; Drug Synergism; Drug Therapy, Combination; Gram-Negative Bacterial Infections; Kinetics; Mice; Microbial Sensitivity Tests; Minocycline; Survival Analysis | 2001 |
Urinary tract infection in neurogenic bladder.
Topics: Acute Disease; Anti-Infective Agents, Urinary; Carbapenems; Cephalosporins; Chronic Disease; Epididymitis; Escherichia coli Infections; Female; Fever; Gram-Negative Bacterial Infections; Humans; Klebsiella Infections; Male; Prostatitis; Pseudomonas Infections; Pyelonephritis; Urinary Bladder; Urinary Bladder, Neurogenic; Urinary Catheterization; Urinary Tract Infections | 2001 |
Oligella ureolytica in blood culture: contaminant or infection?
Topics: Anti-Bacterial Agents; Azithromycin; Ceftriaxone; Cefuroxime; Cephalosporins; Gram-Negative Anaerobic Bacteria; Gram-Negative Bacterial Infections; Humans; Infant; Male; Pneumonia | 2001 |
Neisseria elongata subsp. elongata, as a cause of human endocarditis.
Topics: Aged; Ceftriaxone; Cephalosporins; Endocarditis, Bacterial; Female; Gram-Negative Bacterial Infections; Humans; Neisseria | 2001 |
[Distribution and drug-resistance of 345 strains gram-negative bacilli from hospitalized patients with lower respiratory tract infections diseases].
Topics: Bronchiectasis; Cefotaxime; Cephalosporins; Drug Resistance, Microbial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Klebsiella pneumoniae; Lung Diseases, Obstructive; Pseudomonas aeruginosa; Respiratory Tract Infections | 1998 |
[Prophylaxis with Tercef of infection-related complications following cesarean section].
Topics: Antibiotic Prophylaxis; Cefazolin; Ceftriaxone; Cephalosporins; Cesarean Section; Female; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Injections, Intravenous; Pregnancy; Risk Factors; Time Factors | 2001 |
Lipopolyamines as a therapeutic strategy in experimental Gram-negative bacterial sepsis.
Topics: Animals; Bacteremia; Ceftazidime; Cephalosporins; Disease Models, Animal; Drug Therapy, Combination; Fatty Acids, Monounsaturated; Gram-Negative Bacterial Infections; Neutropenia; Rats; Sepsis; Survival Analysis | 2001 |
Survival of irradiated mice treated with WR-151327, synthetic trehalose dicorynomycolate, or ofloxacin.
Topics: Adjuvants, Immunologic; Animals; Anti-Infective Agents; Ceftriaxone; Cephalosporins; Cord Factors; Female; Gamma Rays; Gram-Negative Bacterial Infections; Liver; Mice; Mice, Inbred Strains; Neutrons; Ofloxacin; Organothiophosphorus Compounds; Radiation Injuries, Experimental; Radiation Tolerance; Radiation-Protective Agents; Survival Rate | 1994 |
Parallel analysis of individual and aggregated data on antibiotic exposure and resistance in gram-negative bacilli.
Topics: Ampicillin; Anti-Bacterial Agents; Cephalosporins; Cohort Studies; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Fluoroquinolones; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; Male; Middle Aged; Pseudomonas; Pseudomonas Infections; Statistics as Topic; Sulbactam | 2001 |
Is it reasonable to use third generation cephalosporins to treat animals?
Topics: Animals; Cephalosporin Resistance; Cephalosporins; Cross Infection; Gram-Negative Bacterial Infections; Hospitals, Animal; Humans; Microbial Sensitivity Tests; Zoonoses | 2001 |
Antimicrobial susceptibilities among clinical isolates of extended-spectrum cephalosporin-resistant Gram-negative bacteria in a Taiwanese University Hospital.
Topics: Cefotaxime; Ceftazidime; Cephalosporin Resistance; Cephalosporins; Cross Infection; Drug Prescriptions; Drug Resistance, Microbial; Gram-Negative Bacterial Infections; Hospitals, University; Humans; Taiwan | 2002 |
[Acute subdural abscess due to mixed infection of Eikenella corrodens and Streptococcus constellatus].
Topics: Acute Disease; Brain; Cefotaxime; Cephalosporins; Child; Eikenella corrodens; Empyema, Subdural; Female; Gram-Negative Bacterial Infections; Humans; Magnetic Resonance Imaging; Streptococcal Infections | 2001 |
[Sensitivity of multiresistant bacterial strains to imipenem (Tienam)].
Topics: Aminoglycosides; Anti-Bacterial Agents; Cephalosporins; Drug Resistance, Microbial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; In Vitro Techniques; Infant, Newborn; Microbial Sensitivity Tests | 1992 |
The activity of ceftiofur sodium for Aeromonas spp. isolated from ornamental fish.
Topics: Aeromonas; Aeromonas hydrophila; Animals; Cephalosporins; Fish Diseases; Fishes; Gram-Negative Bacterial Infections; Microbial Sensitivity Tests | 1992 |
[Clinical study of cefclidin on bacterial prostatitis].
Topics: Adult; Aged; Cephalosporins; Drug Evaluation; Gram-Negative Bacterial Infections; Humans; Male; Middle Aged; Prostatitis | 1992 |
Evaluation of the improvement of cephems on the prophylaxis of pelvic infection after radical hysterectomy.
Topics: Cephalosporins; Female; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Hysterectomy; Japan; Middle Aged; Pelvic Inflammatory Disease; Premedication; Retrospective Studies; Surgical Wound Infection | 1991 |